Effects of Maternal Folic Acid Supplementation on Skeletal Muscle Function and Metabolism in Male and Female CD-1 Mouse Offspring by Saint, Caitlin
Effects of Maternal Folic Acid Supplementation on Skeletal Muscle Function and 
Metabolism in Male and Female CD-1 Mouse Offspring 
 
 
 
 
 
 
 
 
Caitlin Saint, BSc Health Science 
 
 
 
 
 
 
 
 
 
 
 
Submitted in partial fulfillment of the requirements for the degree  
Master of Science in Applied Health Sciences 
(Health Science) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Faculty of Applied Health Sciences 
Brock University, St. Catharines, Ontario 
 
 
 
 
 
© October 2016  
	  	  
	   	   	  ii	  
ABSTRACT 
 
In 1998, folic acid (FA) fortification of all white flour, enriched pasta and 
cornmeal products became mandatory in Canada to reduce the risk of neural tube defects 
at birth. Furthermore, Health Canada and the Society of Obstetricians and Gynaecologists 
of Canada recommends all women take daily prenatal FA supplements in addition to FA-
fortified foods during pregnancy, resulting in pregnant women being exposed to 
approximately 4 times higher FA during pregnancy than the current recommended 
guidelines. However, the influence of maternal FA supplementation on offspring 
development, specifically muscle, is currently unknown. Skeletal muscle is one of the 
most abundant tissues in the human body and is essential for locomotion and energy 
metabolism.Thus, the purpose of this study was to determine the effect of supplemental 
FA (4 times higher than normal dietary consumption), in utero and throughout suckling 
on muscle function and metabolism in male and female CD-1 mouse offspring. The 
major findings were ~25% faster contractions in EDL, characterized by a more rapid 
relaxation rate, and ~15% slower contractions, characterized by a reduced force 
development rate, in SOL among females in FA group, with no differences in contractile 
function seen between groups in males. Additionally, carbohydrate metabolism markers 
in the FA group decreased in SOL among females, whereas, carbohydrate and oxidative 
metabolism markers increased in EDL and SOL, respectively, among males. These 
findings suggest that exposure to folic acid supplementation in utero and throughout 
suckling programs skeletal muscle function and metabolism in a sex-specific manner.    
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CHAPTER 1.0 – GENERAL INTRODUCTION 
 
1.1. Skeletal Muscle 
Skeletal muscle is the one of the most abundant tissues in the human body 
comprising approximately 40% of total body weight in healthy individuals (Frontera & 
Ochala, 2015; Hopkins, 2006).	  Skeletal muscle is a contractile tissue essential for 
locomotion. Muscle is remarkable in its ability to convert chemical energy into 
mechanical energy to produce force with extreme efficiency (Frontera & Ochala, 2015). 
Additionally, skeletal muscle is an important metabolic tissue playing a major role in 
basal energy metabolism, glucose metabolism, oxidative phosphorylation, and 
thermogenesis (Frontera & Ochala, 2015).	  
1.1.1 Structure 
Skeletal muscle is composed of many individual muscle fibres, also referred to as 
muscle cells, which run parallel to one another spanning the length of the muscle. Each 
muscle fibre is comprised of a sarcolemma, sarcoplasm, transverse (T)-tubules, 
sarcoplasmic reticulum (SR), mitochondria and protein. The sarcolemma is a three-
layered cell membrane, which includes a lipid bilayer sandwiched between a basement 
membrane and a submembranous cytoskeletal network (Campbell & Stull, 2003; Ozawa, 
Nishino, & Nonaka, 2001). The two outer membranes are structurally tough layers 
protecting the lipid bilayer from injury, allowing it to remain intact, maintaining its 
structure and function. In addition to regulating metabolites, the sarcolemma is a unique 
membrane as it is excitable, thus, the sarcolemma is fundamental for skeletal muscle 
metabolism and initiating muscle contractions. The T-tubules are invaginations of the 
sarcolemma that conduct excitable signals into the cell (Frontera & Ochala, 2015). The T-
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tubules are found sandwiched between terminal cisterna from the SR forming a triad (Al-
Qusairi & Laporte, 2011; Sorrentino, 2004). The SR is a storage site for calcium (Ca2+) 
dedicated to maintaining Ca2+ homeostasis within the muscle fibre (Frontera & Ochala, 
2015; Sorrentino, 2004). The mitochondria generate the energy required for muscle 
functions through adenosine triphosphate (ATP) synthesis (Frontera & Ochala, 2015, 
Hood, 2001). There are two types of mitochondria found in skeletal muscle, 
subsarcolemmal (SS) and intermyofibrillar (IMF). SS mitochondria represent 
approximately 10-15% of total mitochondria and are located beneath the sarcolemma, 
whereas, IMF mitochondria are embedded within the myofibrils (Hood, 2001). Each 
individual muscle fibre is composed of bundles of myofibrils containing myofilaments 
(proteins). The most abundant myofilaments, thin (actin) and thick (myosin), are arranged 
in repeated units of sarcomeres parallel to one another (Frontera & Ochala, 2015; 
Hopkins, 2006; Kaya et al., 2014). The sarcomere is the smallest contractile unit of an 
individual fibre that provides skeletal muscle with its characteristic striated appearance. 
Two other regulatory proteins, tropomyosin and the troponin complex, are critical to 
muscle contraction. The troponin complex is composed of three subunits: troponin T 
(attaches to tropomyosin), troponin I (inhibits actin-myosin binding), and troponin C 
(binds Ca2+) (Gordon et al., 2000; Hopkins, 2006; Koubassova & Tsaturyan, 2011). 
Troponin T is attached to tropomyosin, which lies in the grooves between actin filaments 
(Gordon et al., 2001). At rest, troponin I attaches to the actin filament blocking the 
myosin-binding site, preventing contraction (Gordon et al., 2001; Gordon et al., 2000; 
Hopkins, 2006). 
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1.1.2 Contraction 
 
 For a contraction to initiate, an electrical impulse (action potential) travels down a 
motor neuron to the presynaptic region, or terminal nerve ending, opening voltage-gated 
Ca2+ channels allowing an influx of Ca2+ into the presynaptic region (Kaya et al., 2014; 
Tintignac et al., 2015). The influx of Ca2+ triggers synaptic vesicle exocytosis and the 
subsequent release of the neurotransmitter, acetylcholine (ACh), into the synaptic region 
(Kaya et al., 2014; Tintignac et al., 2015). ACh travels across the synaptic region binding 
to nicotinic acetylcholine receptors (AChR) located in the postsynaptic region of the 
muscle fibre (Tintignac et al., 2015). The binding of ACh to AChR triggers the opening 
of voltage-gated sodium (Na+) and potassium (K+) channels located within the 
sarcolemma, causing a rapid influx of Na+ into the cell and an efflux of K+ ions out of the 
cell,  depolarizing the cell (Hopkins, 2006; Kaya et al., 2014). A wave of depolarization 
(action potential) spreads across the sarcolemma and into the cell via the T-tubules, 
arriving at the triad (Frontera & Ochala, 2015; Hopkins, 2006; Schneider, 1994). The 
action potential causes a conformational change to the voltage sensing dihydropyridine 
receptors (DHPR) located within the T-tubules (Hopkins, 2006; Kaya et al., 2014; Ríos & 
Pizarro, 1991; Schneider, 1994). The conformational change of DHPR triggers the 
opening of the ryanodine receptor (RyR), which are Ca2+ channels located on the terminal 
cisternae of the SR, causing an influx of Ca2+ from the SR into the sarcoplasm of the cell 
(Hopkins, 2006; Imagawa et al., 1987; Kaya et al., 2014; Ríos & Pizarro, 1991; Schneider, 
1994). In the sarcoplasm, Ca2+ binds to troponin C causing a conformational change to 
troponin I, exposing the myosin-binding site on the actin filament (Gómez et al., 2006; 
Gordon et al., 2001; Gordon et al., 2000; Hopkins, 2006). An ATP molecule binds to the 
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myosin head in a rigor state leading to subsequent detachment of myosin from actin, 
initiating the cross-bridge cycle (Cooke, 1997; Koubassova & Tsaturyan, 2011; Llinas et 
al., 2015; Lymn & Taylor, 1971). Prior to myosin binding to a new actin filament, ATP is 
hydrolyzed by myosin ATPase, located on the myosin head, producing adenosine 
diphosphate (ADP) and inorganic phosphate (Pi) (Koubassova & Tsaturyan, 2011; Llinas 
et al., 2015; Lymn & Taylor, 1971). The myosin head weakly binds to actin with its 
hydrolysis by products (ADP + Pi) and the sequential release of Pi triggers the transition 
from weak to strong myosin binding, resulting in the power stroke (Cooke, 1997; 
Koubassova & Tsaturyan, 2011; Llinas et al., 2015; Rayment et al., 1993). After the 
power stroke is complete, ADP is released and the cross-bridge is in a rigor state 
(Koubassova & Tsaturyan, 2011; Llinas et al., 2015). To prepare for the next cross-bridge 
cycle, ATP re-binds to the myosin head causing dissociation of myosin from actin.  In 
order for relaxation to occur, Ca2+ must be removed from the sarcoplasm and translocated 
back into the SR. Removal of Ca2+ allows the tropomyosin-troponin I complex to block 
the myosin-binding site on actin, preventing contraction (Gordon et al., 2000; Hopkins, 
2006; Koubassova & Tsaturyan, 2011). Re-uptake of Ca2+ into the SR occurs through the 
sarco(endo)plasmic reticulum calcium ATPase (SERCA) pump located in the SR (Kaya 
et al., 2014; Stammers et al., 2015) 
 1.1.3 Muscle Fibre Types 
Skeletal muscles are composed of different types of muscle fibres that are 
responsible for a wide variety of functions. Skeletal muscle fibre types are classified into 
three main categories based on their contractile and metabolic properties: type I (SO; 
slow oxidative), type IIa (FOG; fast oxidative glycolytic), type IIb, (FG; fast glycolytic), 
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and a hybrid of type IIa and IIb fibres characterized as type IId/x (Bär & Pette, 1988; 
Bottinelli & Reggiani, 2000; Delp & Duan, 1996; Termin et al., 1989). 
Type I fibres are used for continuous low-intensity activities, such as maintaining 
posture and stability (Schiaffino, 2010). Type I fibres are rich in aerobic oxidative 
enzymes that rely on carbohydrates and lipids to produce ATP (Bottinelli & Reggiani, 
2000; Rivero et al., 1998; Schiaffino, 2010). Type I fibres are able to transport substrates, 
such as glucose and fatty acids, across the sarcolemma at a faster rate than type II fibres, 
allowing for greater ATP synthesis (Bottinelli & Reggiani, 2000). In addition to increased 
substrate availability, type I fibres have high mitochondrial and myoglobin content and 
increased capillary density making them highly fatigue resistant and excellent for 
prolonged submaximal activities (Bottinelli & Reggiani, 2000; Schiaffino, 2010). Due to 
their high sensitivity to Ca2+, type I fibres are the first to be recruited for activities 
(Bottinelli & Reggiani, 2000; Trinh & Lamb, 2006). Furthermore, type I fibres are 
characterized by long, slow contraction and relaxation times compared to type II fibres. 
The length and speed of muscle contraction depends on myosin ATPase activity (ATP 
hydrolysis rate) and the speed of Ca2+ uptake by the SR, which is slow in type I fibres 
(Baylor & Hollingworth, 2003; Bottinelli & Reggiani, 2000; Schiaffino, 2010; Trinh & 
Lamb, 2006).  
Type IIa fibres are used for prolonged anaerobic activities, such as walking 
(Schiaffino & Reggiani, 201l). Type IIa fibres contain aerobic oxidative and glycolytic 
enzymes, thus, they are fatigue resistant with the ability to participate in continuous 
activities (Rivero et al., 1998; Schiaffino, 2010). These fibres have a faster, shorter 
contraction and relaxation speed compared to type I fibres, due to their higher myosin 
	  	  
	   	   	  6	  
ATPase activity and quicker Ca2+ uptake (Baylor & Hollingworth, 2003; Bottinelli & 
Reggiani, 2000; Trinh & Lamb, 2006).  
Type IIb fibres are involved in high power, anaerobic activities for short periods 
of time, such as jumping (Bottinelli & Reggiani, 2000). Type IIb fibres depend on 
glycolytic enzymes that generate ATP rapidly, however, glycolysis depletes glycogen 
stores rapidly. Additionally, type IIb fibres have low mitochondria and myoglobin 
content and the lowest capillary density, making these fibres highly fatigable (Rivero et 
al., 1998; Schiaffino, 2010). Type IIb fibres have the fastest and shortest contraction and 
relaxation time with the greatest power output, however, type IIb fibres have the lowest 
Ca2+ sensitivity, thus, these fibres are the last to be recruited (Baylor & Hollingworth, 
2003; Bottinelli & Reggiani, 2000; Schiaffino, 2010; Trinh & Lamb, 2006). 
Type IId/x fibres are also used in short duration, high power activities and rely on 
glycolysis for ATP synthesis (Schiaffino & Reggiani, 201l). Type IId/x fibres have 
contraction and relaxation times similar to IIb fibres, however, their resistance to fatigue 
is slightly greater than type IIb fibres (Schiaffino, 2010). Table 1.1 highlights the 
differences in physical, metabolic and contractile characteristics of each fibre type (I, IIa, 
IIx/d, IIb). 
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Table 1.1  Physical, metabolic, and contractile characteristics of skeletal muscle fibres 
(Adapted from Fajardo, 2011; Zibamanzarmofrad, 2015). 
 
Characteristics Type 1 Type IIa Type IId/x Type IIb 
Diameter Small1  Intermediate1 Large1 Largest1 
Glycolytic capacity Low2,3 Intermediate2,3 High2,3 Highest2,3 
Oxidative capacity High1,2,3 High1,2,3 Intermediate1,2,3 Low1,2,3 
Mitochondria  Abundant2 Abundant2 Few2 Fewer2 
Myoglobin  High2 Intermediate2 Low2 Lowest2 
Capillaries Abundant2.4 Intermediate2,4 Sparse2,4 Rare2,4 
Glycogen Low2,4 Intermediate2,4 High2,4 Higher2,4 
ATP synthesis Aerobic2,4 Aerobic2,4 Anaerobic2,4 Anaerobic2,4 
ATP consumption  Low2,4 Intermediate2,4 High2,4 Highest2,4 
Myosin ATPase Slow2,4 Intermediate2,4 Fast2,4 Fastest2,4 
Motor unit size  Small2 Intermediate2 Large2 Largest2 
Recruitment Early1,4 Intermediate1,4 Late1,4 Later1,4 
Contraction Slow2,4 Fast2,4 Faster2,4 Fastest2,4 
Relaxation Slow2,4 Fast2,4 Faster2,4 Fastest2,4 
Twitch Long2,4 Short2,4 Shorter2,4 Shortest2,4 
Resting [Ca2+] High2,4  Intermediate2,4 Low2,4 Lowest2,4 
Ca2+ uptake  Slow2,5 Intermediate2,5 Fast2,5 Fastest2,5 
Delp & Duan, 19961, Schiaffino & Reggiani, 20112, Rivero et al., 19983, Bottinelli & 
Reggiani, 20004, Baylor & Hollingworth, 20035 
Ca2+: calcium; [Ca2+]: calcium concentration 
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1.1.4 Mechanics 
Force production in skeletal muscle is highly dependent on structural and 
biochemical alterations within the muscle fibre. Furthermore, fast and slow twitch muscle 
fibre compositions play a critical role in biochemical function. The interaction between 
the force generated by the muscle, muscle load, and the number of cross-bridge 
formations results in three types of muscle contractions: 1) concentric or shortening of the 
muscle during contraction; 2) isometric or no length change in the muscle during 
contraction and; 3) eccentric or lengthening of the muscle during contraction (Frontera & 
Ochala, 2015). Isometric contractions are useful for studying the basic mechanisms 
behind contraction and relaxation, such as rates of contraction and Ca2+ release 
(Schiaffino & Reggiani, 2011), therefore, only the details of isometric contractions will 
be discussed further in this review.  
As discussed previously, the cross-bridge cycle leads to a contractile response 
from muscle tissue. A twitch contraction occurs when a single stimulus at a low 
frequency (1 Hz) results in a single contraction and relaxation cycle of the muscle. 
Intracellular Ca2+ transients and Ca2+ sensitivity of muscle fibres determine the amplitude 
of the twitch force, thus, twitch force is an indicator of potential changes to Ca2+signaling 
(Schiaffino & Reggiani, 2011). A tetanic contraction occurs when repeated and rapid 
stimuli at a greater frequency (150 Hz), results in amplified, sustained muscle contraction, 
indicating the muscle has reached peak force production. In contrast to a twitch 
contraction, tetanic contraction is determined by the number of active cross-bridges, as 
well as, peak Ca2+ concentration in the cytoplasm (Schiaffino & Reggiani, 201l).  
The length-tension relationship is the relationship between a muscle’s length and 
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the force it generates during an active contraction in an isometric state. Furthermore, the 
force a muscle generates is a reflection of the degree of overlap between thick and thin 
filaments (Close, 1972). Thus, the force generated during an isometric contraction 
depends on the length of the muscle. Peak force production occurs at the optimal length 
(Lo) of the muscle, which is characterized by a maximal overlap of thick and thin 
filaments, resulting in peak tetanic tension (Close, 1972). Additionally, biochemical 
alterations, such as Ca2+ kinetics, have a direct impact on the contractile properties of 
skeletal muscle fibres. Isometric twitch fibres with faster Ca2+ transients reach a greater 
peak at a quicker rate, characterized by a shorter time to peak tension (TPT, defined as 
the time (ms) it takes from the onset of an active contraction to the peak tension 
produced) and ½ relaxation time (½ RT, defined as the time (ms) it takes for the muscle 
to return to 50% of peak tension) and faster rates of force development (+dP/dt) and 
relaxation (-dP/dt) (Schiaffino & Reggiani, 201l) (Figure 1.1.A). The twitch:tetanus 
(Pt:Po) ratio compares the two types of forces, peak twitch (Pt) and peak tetanic (Po) 
tension, to one another. In comparison to slow twitch fibres, there is a higher Pt:Po ratio 
seen in fast twitch fibres. Moreover, intracellular Ca2+ transients, peak cytoplasmic Ca2+ 
concentration and Ca2+ sensitivity are all greater in fast twitch fibre types (Schiaffino & 
Reggiani, 201l). Thus, fast twitch fibre types (extensor digitorum longus; EDL) are 
associated with a greater Pt characterized by a shorter TPT and ½ RT, faster +dP/dt and -
dP/dt, as well as, greater Po, compared to slow twitch fibre types (soleus; SOL) (Figure 
1.1B). 
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Figure 1.1. A) Representation of the isometric contractile parameters measured from the 
twitch force trace. B) Comparison of an isometric peak twitch force trace between 
glycolytic fast twitch muscle fibres (EDL) and oxidative slow twitch muscle fibres (SOL). 
Data taken from the current study. Pt, peak twitch; TPT, time to peak tension; ½ RT, half-
relaxation time, +dP/dt, rate of force development; -dP/dt, rate of relaxation; EDL, 
extensor digitorum longus; SOL, soleus 
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1.1.5 Metabolism 
 
During skeletal muscle contraction, the majority of energy consumption is from 
molecular motors and ion pumps. The three major energy consuming ATPase’s are 
myosin ATPase, Ca2+ ATPase, and Na+/K+ ATPase, used for cross-bridge formation and 
maintaining ion homeostasis, respectively (Cornelius & Mahmmoud, 2003). The energy 
source required for cellular functions, including contractile activity, is ATP, which is 
produced via metabolic pathways. The main mechanisms that provide ATP to skeletal 
muscle are carbohydrate and lipid metabolism, and to a lesser degree protein metabolism 
(which will not be discussed further).  
i) Carbohydrate Metabolism 
Glycolysis (Figure 1.2) is the catabolic pathway that breaks down carbohydrates 
to produce energy (ATP) in the cytosol of muscle fibres. Glycolysis occurs under two 
conditions: 1) anaerobic (does not involve mitochondria) and; 2) aerobic (involves 
mitochondria). Anaerobic glycolysis is a 10-step pathway which converts glucose into 
two pyruvate molecules. Briefly, glucose molecules, which are generated by the 
breakdown of glycogen stores in skeletal muscle or transported across the sarcolemma 
via GLUT proteins, are broken down into two molecules of pyruvate, producing two ATP 
molecules during the process (Schiaffino & Reggiani, 201l). Glycolysis is initiated by the 
phosphorylation of glucose to glucose-6-phosphate, which is catalyzed by the enzyme 
hexokinase (HK) (Figure 1.2). Glucose-6 phosphate is converted into fructose-6-
phosphate by the removal of one carbon via phosphoglucose isomerase. 
Phosphofructokinase (PFK) is the rate-limiting enzyme of glycolysis, which catalyzes the 
phosphorylation of fructose-6-phospate to yield fructose-1,6-biphosphate (Al Hasawi et 
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al., 2014; Nordenberg et al., 1981) (Figure 1.2). Through a series of additional subsequent 
reactions, two pyruvate, two NADH and two ATP molecules are produced. If the cell is 
deficient in substrates, pyruvate molecules are converted into lactate to aid in the 
regeneration of NAD to continue anaerobic glycolysis. However, if mitochondria are 
involved, pyruvate molecules are transported across the inner mitochondrial membrane 
and converted into acetyl-CoA by pyruvate dehydrogenase to undergo oxidative 
phosphorylation (Figure 1.3). 
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Figure 1.2. Glycolytic pathway in the cytosol highlighting (in red) two key enzymes, 
hexokinase (HK) and phosphofructokinase (PFK), that play an important regulatory role 
in the breakdown of carbohydrates into pyruvate molecules. ADP, adenosine 
diphosphate; ATP, adenosine triphosphate; NADH, nicotinamide adenine dinucleotide + 
hydrogen. 
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Figure 1.3. Pyruvate metabolism. Pyruvate is broken down into acetyl-CoA molecules 
via pyruvate dehydrogenase (PDH) in the mitochondria of the cell. NAD+, nicotinamide 
adenine dinucleotide; NADH, nicotinamide adenine dinucleotide + hydrogen. 
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ii) Lipid Metabolism 
Triglycerides are broken down into glycerol and three fatty acid molecules and 
used for oxidative metabolism. Glycerol becomes a substrate entering glycolysis, whereas, 
fatty acid molecules undergo β-oxidation producing acetyl-CoA. Initially, long-chain 
fatty acid molecules are converted to fatty acyl-CoA by long-chain fatty acyl-CoA 
synthetase (FACS) for transport across the outer and inner mitochondrial membranes 
(Gargiulo et al., 1999) (Figure 1.4).  Long-chain fatty acyl-CoA molecules are 
transported from the cytosol into the mitochondria via carnitine acyltransferase, with 
carnitine palmitoytransferase (CPT) being the most often studied (Figure 1.4). CPT is the 
rate-limiting step in the transport of long-chain fatty acids into the mitochondrial matrix 
(Rakheja et al., 2002). Once the long-chain fatty acyl-CoA molecules have entered the 
mitochondrial matrix, they undergo β-oxidation, where each 2-carbon acyls bind with a 
CoA molecule, producing acetyl-CoA. 3-Hydroxyacyl-CoA dehydrogenase (β-HAD) is 
an enzyme that regulates the oxidation of long-chain fatty acids within the mitochondria 
by catalyzing the oxidation of L-3-hydroxyacyl CoA by NAD+ (Aragao et al., 2014) 
(Figure 1.4). Therefore, β-HAD is a key enzyme in the β-oxidation of fatty acids.  
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Figure 1.4.  Schematic diagram representing the breakdown of lipids in the mitochondria 
of the cell. Carnitine palmitoyaltransferase (CPT) and 3-Hydroxyacyl-CoA 
dehydrogenase (β-HAD), are two key enzymes (highlighted in red) that play an important 
regulatory role in the breakdown of lipids into acetyl-CoA.  
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iii) Oxidative Phosphorylation 
Acetyl-CoA (derived from pyruvate and β-oxidation, as discussed previously) 
enters the tricarboxylic acid cycle (TCA cycle) by combining with oxaloacetate (the last 
intermediate of the TCA cycle) to produce citrate via citrate synthase (CS) (Figure 1.5). 
CS is a key marker of oxidative metabolism as it correlates with mitochondrial volume 
density in skeletal muscle and plays a key regulatory role in the TCA cycle (Aragao et al., 
2014; Esteva et al., 2009). The citrate molecule then goes through a series of reactions, 
completing the TCA cycle as an oxaloacetate molecule, producing 3 NADH, 1 FADH2, 2 
CO2 and 1 ATP molecule (Figure 1.5).  
Coenzymes (NADH and FADH2) transfer electrons to proteins in the electron 
transport chain (ETC), located on the inner mitochondrial membrane, converting energy 
to ATP (Figure 1.6). The energy from the transferred electrons pumps protons (H+ ions) 
from the mitochondrial matrix to the intermembrane space, creating an electrochemical 
gradient. As the H+ ions move back into the mitochondrial matrix, ATP formation is 
coupled to ATP synthase (Sazanov, 2015). Briefly, NADH dehydrogenase (complex I) is 
the first enzyme of the ETC which receives electrons from NADH and transfers them to 
ubiquinone (Coenzyme Q). Succinate dehydrogenase (complex II), the second enzyme of 
the ETC, is unique as it is also part of the TCA cycle. Complex II receives electrons 
(FADH2) from succinate (a TCA cycle intermediate), which are then transferred to 
coenzyme Q (Sazanov, 2015). Coenzyme Q passes the electrons onto cytochrome bc1 
(complex III), which then transfers the electrons to cytochrome c oxidase (COX; complex 
IV) (Figure 1.6). COX is the terminal electron acceptor of the ETC which transfers 
electrons to oxygen producing water molecules, while pumping H+ ions across the 
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mitochondrial membrane (Sazanov, 2015). COX is the rate-determining enzyme of the 
mitochondrial ETC, which is a major determinant of mitochondrial respiratory capacity 
in skeletal muscle. ATP synthase (complex V) is the final enzyme in the ETC pathway. 
As the H+ ions move back into the mitochondrial matrix, complex V uses the energy 
stored from the proton gradient to drive the synthesis of ATP from ADP and phosphate 
(Pi) (Sazanov, 2015) (Figure 1.6). 
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Figure 1.5. Tricarboxylic acid (TCA) cycle. Acetyl-CoA enters the TCA cycle 
combining with oxaloacetate via citrate synthase (CS), a key regulatory enzyme in the 
TCA cycle correlating to mitochondrial volume density. ADP, adenosine diphosphate; 
ATP, adenosine triphosphate; FAD, flavin adenine dinucleotide; FADH2, flavin adenine 
dinucleotide + 2 hydrogen; NAD+, nicotinamide adenine dinucleotide; NADH, 
nicotinamide adenine dinucleotide + hydrogen. 
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Figure 1.6. The Electron Transport Chain (ETC) located on the inner mitochondrial 
membrane. Electrons are transferred from protein to protein (Complex I – IV), releasing 
energy (H+ ions) and driving ATP synthesis. Cytochrome c oxidase (COX; complex IV) 
is an important enzyme that is a major determinant of mitochondrial respiratory capacity 
in skeletal muscle. Q, ubiquinone, ADP, adenosine diphosphate; ATP, adenosine 
triphosphate; C, cytochrome C; FAD, flavin adenine dinucleotide; FADH2, flavin adenine 
dinucleotide + 2 hydrogen; H+, hydrogen ion; H2O, water; NAD+, nicotinamide adenine 
dinucleotide; NADH, nicotinamide adenine dinucleotide + hydrogen; O2, oxygen.  
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1.1.6 Sex Differences in Skeletal Muscle Function and Metabolism 
It has been well documented there are sex differences in skeletal muscle 
morphology. Males have an overall greater muscle mass compared to females, which 
may be attributed to the larger cross-sectional area of individual muscle fibres seen in 
men compared to women (Haizlip et al., 2015; Lundsgaard & Kiens, 2014). Additionally, 
male and female mice express variations in fibre type composition within the same 
muscle. For example, males express 58% type IIa muscle fibres, whereas, females 
express only 36% in mice SOL (Haizlip et al., 2015). These differences are also seen in 
the plantaris (IIa - 16%, males; 37%, females) and tibialis anterior (IIa - 39%, males; 25%, 
females) muscles (Haizlip et al., 2015). Furthermore, myosin heavy chain (MHC) isoform 
expression varies between men and women, with women expressing a greater proportion 
of MHCI and fewer MHCIIa and MHCIIx in the vastus lateralis compared to men 
(Lundsgaard & Kiens, 2014).  
MHC isoform expression is associated with fibre-type morphology, contractile 
function and enzymatic characteristics of skeletal muscle (Haizlip et al., 2015; 
Lundsgaard & Kiens, 2014). Maximal rates of force development and relaxation and 
contractile velocity is significantly lower in females compared to males which correlates 
with the greater proportion of slow twitch type I fibres found in female skeletal muscle 
tissue (Haizlip et al., 2015). Additionally, glucose and lipid metabolism are highly 
correlated with the enzymatic characteristics of muscle fibres. Glycolytic capacity 
appears to be greater in men compared to woman, characterized by a higher maximal 
activity of PFK and other carbohydrate related metabolic markers, which may be due to 
the greater percentage of type II fibres found in males (Lundsgaard & Kiens, 2014). In 
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contrast, women express higher levels of CPT-1 and increased β-oxidation capacity 
compared to men, which is likely attributed to the greater proportion of type I oxidative 
fibres found in female skeletal tissue (Lundsgaard & Kiens, 2014). Additionally, maternal 
protein restriction results in increased carbohydrate metabolism genes in skeletal muscle 
tissue of female, but not male, offspring, indicating sex-specific differences (Zheng et al., 
2012). Due to the observed differences between sexes, the current study will examine 
males and females separately since responses to an intervention may be sex-specific.  
1.2. Nutritional Programming 
 
Nutritional programming refers to the concept that nutrients consumed in utero 
and through lactation can have profound long-term effects on a tissue’s growth and 
metabolism such that differences in susceptibility to chronic diseases are observed at 
adulthood (Langley-Evans, 2009; Yan et al., 2013). Nutritional programming has been 
studied extensively in a cohort of term singletons that were exposed to the Dutch Winter 
Famine (1944-1945) in utero with daily rations below 1000 calories for a minimum of 13 
weeks. The Dutch Winter Famine provided a unique and ‘natural’ opportunity for 
researchers to study the link between the development of chronic diseases in adulthood 
with a short, but severe, period of maternal undernutrition during pregnancy. Researchers 
found individuals exposed to the famine in utero were associated with an increased 
incidence of cardiovascular disease, metabolic disorders, obesity and mortality compared 
to unaffected individuals, independent of birth weight (Chmurzynska, 2010; Painter et al., 
2006; Painter et al., 2005; van Abeelen et al., 2012), suggesting low birth weight is not 
the only predictor of poor health at adulthood. The Dutch Winter Famine is one example 
that suggests that maternal undernutrition creates and imbalance between nutrient supply 
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and fetal demands, and may have a long-lasting disruption in the health trajectory of the 
offspring. Additionally, researchers have shown that maternal undernutrition of specific 
micronutrients, such as folic acid, can be detrimental to the fetus (Finglas, 2003; Iyer & 
Tomar, 2009; Lindzon & O’Connor, 2007). However, the effect of maternal 
supplementation with folic acid during pregnancy and lactation, on offspring health is 
less understood. 
1.2.1 Early Dietary Factors Affecting Skeletal Muscle Function and 
Metabolism  
Mesenchymal stem cells are a subset of quiescent mononuclear satellite cells 
critical for muscle tissue development, growth and repair. During fetal development, stem 
cells are committed to a myogenic lineage via regulatory proteins, subsequently 
proliferating, differentiating and fusing to become mature muscle fibres (Woo et al., 
2011; Yan et al., 2013). Skeletal muscle fibres develop prenatally, thus, muscle fibre 
numbers are determined prior to birth. Alternatively, muscle mass is increased due to 
fibre size (hypertrophy), not quantity, postpartum (Walter & Klaus, 2014; Woo et al., 
2011). In utero, skeletal muscle growth and development is largely affected by the 
intrauterine environment, thus, factors, such as diet, can alter both skeletal muscle 
function and metabolism of offspring in adulthood via nutritional programming. 
Therefore, the remainder of this review will discuss the effects of nutritional 
programming from a maternal diet, during gestation and/or lactation, on offspring skeletal 
muscle tissue at adulthood.  
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i) Maternal Undernutrition 
It has been shown that maternal undernutrition (50% overall reduction in food 
intake) significantly reduced muscle mass, stem cell number and regenerative capacity 
after injury in offspring at 8 weeks of age (Woo et al., 2011). Thus, muscle fibre 
development, associated with stem cell quantity and activity, is highly sensitive to 
nutrient availability during rapid periods of growth, such as fetal development. 
Additionally, previous research has shown protein restriction throughout gestation 
reduced body weight and muscle mass in rat offspring at weaning (Desai et al., 1996). 
Moreover, protein restriction through cross-fostering immediately after birth showed a 
similar effect (Desai et al., 1996), indicating exposure to nutritional insults in utero and 
during suckling are both critical time periods that can affect offspring postnatal skeletal 
muscle development 
Maternal protein restriction, during pregnancy and lactation, has shown DNA 
hypermethylation at the glucose transporter type 4 promotor region (GLUT4) resulted in 
increased GLUT4 expression, as well as regulatory genes associated with carbohydrate 
metabolism, and silenced peroxisome proliferator-activated receptor gamma coactivator 
1-α (PGC-1α) expression in skeletal muscle of female offspring at 18 months of age 
(Zheng et al., 2012; Zeng et al., 2013). PGC-1α stimulates mitochondrial biogenesis, 
regulates skeletal muscle fibre type determination (promoting more oxidative type 1 
fibres), and regulates carbohydrate and lipid metabolism, playing a significant role in the 
regulation of energy metabolism (Liang & Ward, 2006), and  GLUT4 is a transporter 
protein essential for glucose homeostasis (Liang & Ward, 2006; Huang & Czech, 2007). 
Additionally, maternal folate deficiency results in decreased skeletal muscle size and 
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number of male offspring in a swine model immediately after birth (Li et al., 2013). Gene 
chip analysis indicated metabolic shifts in offspring of folate deficient sows. Genes 
related to carbohydrate (HK) and lipid metabolism (CPT) were significantly down-
regulated in folate deficient offspring compared to controls (Li et al., 2013).   
ii) Maternal Overnutrition 
Maternal over-nutrition in animal models, due to diets high in fat (40% energy 
from fat) or Westernized junk food diets (processed foods high in high, sugar and salt), 
during pregnancy and lactation, have shown decreased muscle mass due to reduced 
muscle fibres in offspring at 10 - 12 weeks of age (Bayol et al., 2009; Bayol et al., 2005; 
Walter & Klaus, 2014). Muscle fibres and adipocytes are derived from mesenchymal 
stem cells, which are then committed to a myogenic or adipogenic lineage via regulatory 
proteins during prenatal development (Yan et al., 2013). Maternal overnutrition in animal 
models have shown decreased muscle fibres and increased adipocytes resulting in 
increased intramuscular fat in offspring skeletal muscle (Yan et al., 2013). Furthermore, 
these studies have shown contractile properties are impaired (reduced twitch and tetanic 
tensions), reducing muscle force (Bayol et al., 2009; Walter & Klaus, 2014). Lastly, 
skeletal muscle glucose and fatty acid metabolism and cellular respiration rates were 
shown to be impaired, decreasing substrate availability and, in turn, affecting muscle 
function (Bayol et al., 2005; Claycombe et al., 2015; Walter & Klaus, 2014). Taken 
together, these studies indicate offspring skeletal muscle function and metabolism are 
responsive to suboptimal maternal diets, through both over- and undernutrition. However, 
there is a paucity of studies relating to folic acid supplementation and skeletal muscle. 
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1.3. Nutritional Programming and Folate 
 1.3.1 Folate and Folic Acid 
Folate is a water-soluble B vitamin (B9) fundamental for human health and 
development. Humans are unable to synthesize folate de novo, thus, it must be supplied 
through the diet to meet the recommended daily requirements (Lindzon & O’Connor, 
2007; Lucock, 2000). Folate is a generic term that refers to two forms: a) the naturally 
occurring form found in foods and b) the synthetic form, folic acid, used in food 
fortification and dietary supplements (Blancquaert et al., 2010; Institute of Medicine, 
1998; Iyer & Tomar, 2009). Folic acid, also referred to as pteroylmonoglutamic acid, is 
the most oxidized and stable form of folate, consisting of a fully oxidized aromatic 
pteridine ring attached to a p-aminobenzoic acid molecule and a glutamic acid residue 
(Finglas, 2003; Guéant et al., 2013; Institute of Medicine, 1998; Lindzon & O’Connor, 
2007; Lucock, 2000; Scott, 1999). The chemical structure of naturally occurring folate is 
similar to folic acid, however, there are two distinct structural differences. First, the 
aromatic pteridine ring of natural folate is reduced and second, they are 
pteroylpolyglutamates, thus, they contain additional glutamic acid molecules (1-6) linked 
to the glutamate (Finglas, 2003; Institute of Medicine, 1998; Lucock, 2000; Scott, 1999). 
However, the focus of this thesis will be on the synthetic folic acid form as this form is 
most commonly used in the literature. 
1.3.2 Function of Folic Acid  
 
Folic acid plays a fundamental role in DNA and RNA biosynthesis, DNA repair, 
and DNA methylation processes required for normal metabolism and regulation. Thus, 
adequate folic acid intake is essential for normal cell division and maintaining genome 
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integrity (Bailey & Gregory, 1999; Guéant et al., 2013). Folic acid primarily functions as 
a coenzyme in one-carbon transfer reactions necessary for amino acid and nucleic acid 
metabolism (Bailey & Gregory, 1999; Gregory, 2001). During periods of rapid growth 
and development, such as pregnancy, it is critical folic acid intake is increased due to the 
significant rise in one-carbon transfer reactions necessary for rapid cell division (Iyer & 
Tomar, 2009). The main one-carbon reactions that occur within the cell are: 1) the 
interconversion of serine and glycine; 2) the catabolism of histidine to glutamic acid; 3) 
the synthesis of purine; 4) the synthesis of thymidylate and; 5) the synthesis of 
methionine via remethylation of homocystine (Blancquaert et al., 2010; Gregory, 2001; 
Guéant et al., 2013; Lucock, 2000). A detailed explanation of the intracellular folic acid 
metabolism and the methionine synthesis pathway will be discussed next due to the 
fundamental role it plays in nutritional programming and DNA methylation, however, the 
details of the other one-carbon reactions will only be discussed as needed.  
1.3.3 Intracellular Folic Acid Metabolism 
The folic acid cycle begins as peripheral tissues take up circulating 5-
methyltetrahydrofolate (THF). Intracellularly, 5-methyl THF is demethylated to THF and 
subsequently converted to the polyglutamate form via methionine synthase (from the 
methionine synthesis reaction) and polyglutamate synthase, respectively (Figure 1.7). 
Folic acid is unable to be stored or participate in one-carbon transfer reactions unless it is 
in the reduced polyglutamate THF form (Crider et al., 2012; Finglas, 2003; Kelly et al., 
1997). Additionally, unmetabolized folic acid taken up by peripheral tissues is reduced to 
dihydrofolate and subsequently reduced to THF by dihydrofolate reductase. THF is then 
converted to 5,10-methylene THF and immediately reduced to 5-methyl THF via 
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methylenetetrahydrofolate reductase (MTHFR), for a new folate cycle to begin (Crider et 
al., 2012; Finglas, 2003; Kelly et al., 1997; Wright et al., 2007; Figure 1.7). This reaction 
is integral to methionine synthesis and S-adenosylmethionine (SAM)-mediated 
methylations. As 5-methyl THF is demethylated to THF, the methyl group from 5-methyl 
THF is transferred to homocysteine by methionine synthase, converting homocysteine to 
methionine (Crider et al., 2012; Kelly et al., 1997). Methionine is subsequently converted 
to SAM, a versatile coenzyme and major methyl donor for DNA methylation. DNA 
methylation occurs as methyltransferase transfers a methyl group from SAM to a cytosine 
residue on a DNA strand. During this process, SAM is demethylated to S-
adenosylhomocysteine (SAH), which is then hydrolyzed to homocysteine to begin a new 
methionine synthesis and SAM-mediated methylation cycle (Chmurzynska, 2010; Crider 
et al., 2012; Lucock, 2000; Figure 1.7). 
Additionally, THF, regenerated from the methionine synthesis reaction, is used in 
the formation of 5,10-methylene THF and 10-formyl THF used for the synthesis of 
thymidylate and purine, respectively (Bailey & Gregory, 1999; Chmurzynska, 2010). 
Briefly, in the thymidylate synthesis reaction, 5,10-methyene THF donates a methyl 
group to deoxyuridylate via thymidylate synthesis, converting it to thymidylate for DNA 
synthesis (pathway not shown). Additional dietary nutrients are also necessary to 
maintain methionine synthase reactions. These nutrients include: vitamin B6 (purine 
synthesis), vitamin B12 (methionine synthase function), choline (precursor to betaine), and 
riboflavin (MTHFR stability), however, they will not be discussed further in this review. 
SAM and SAH play a fundamental role in the regulation of intracellular folic acid 
metabolism and methionine synthesis. High concentration of SAM inhibits MTHFR, 
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reducing synthesis of 5-methyl THF and thereby reducing the methylation of 
homocysteine to methionine. In contrast, low concentrations of SAM activate MTHFR 
activity, increasing 5-methyl THF synthesis and homocysteine methylation. Furthermore, 
high concentrations of SAH inhibit methyltransferase activity, resulting in DNA 
hypomethylation.  Thus, hydrolysis of SAH to homocysteine is critical to maintain DNA 
methylation rates (Crider et al., 2012).  
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Figure 1.7 Schematic diagram of intracellular folic acid metabolism involving DNA 
methylation. CH3, methyl group; MTHFR, methylenetetrahydrofolate reductase; SAH, S-
adenosylhomocysteine; SAM, S-adenosylmethionine; THF, tetrahydrofolate (Saint, 
2016). 
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1.3.4 Epigenetics  
Epigenetics refers to alterations in gene expression (phenotype) that occur without 
alterations in DNA sequence (genotype) (Chmurzynska, 2010). Suboptimal maternal 
nutrition during pregnancy and lactation can cause epigenetic alterations of the fetal 
genome, affecting the long-term health and development of offspring (Langley-Evans, 
2009; Wu et al., 2004). The mechanism by which nutritional programming affects tissue 
development has not been well established.  However, it is hypothesized epigenetic 
alterations, such as DNA methylation, may play a role.  
i) DNA Methylation 
Methyl donors, derived from folic acid and methionine consumed in the diet, as 
well as, betaine, vitamin B12 and choline, are necessary for DNA methylation.  Thus, 
early nutrition may influence adult phenotype through epigenetic alterations. DNA 
methylation is a post-replication modification of genomic DNA that alters gene 
expression. Fetal development may alter DNA methylation patterns, resulting in stable 
changes in gene expression that can be maintained throughout an individuals’ lifespan.  
DNA methylation patterns, established by cytosine methylation at specific sites 
along DNA strands, mostly develop in utero (Crider et al., 2012; Lillycrop et al., 2005; 
Waterland & Jirtle, 2003). DNA methylation occurs at the 5’ position of cytosine within a 
cytosine-guanine (CpG) dinucleotide. DNA methyltransferase (Dnmt1) catalyzes DNA 
methylation by transferring a methyl group from a methyl donor, such as SAM, to the 
cytosine residue (Chmurzynska, 2010; Crider et al., 2012; Wu et al., 2004). SAM is a 
universal methyl donor in methyl transfer reactions synthesized from methionine via one-
carbon metabolism reactions, as discussed previously (section 1.3.3. Intracellular Folic 
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Acid Metabolism). Methylation of CpG rich clusters, referred to as CpG islands located at 
the promotor regions of DNA strands, are associated with repressed gene transcription, 
whereas, hypomethylation of CpG islands results in increased transcriptional activity 
(Chmurzynska, 2010; Crider et al., 2012; Lillycrop et al. 2005). The mechanisms by 
which DNA methylation silences gene transcription are not fully understood, however, 
two potential mechanisms have been proposed: 1) DNA methylation directly inhibits 
gene transcription by binding to the promotor regions of DNA, blocking transcriptional 
factors, such as RNA polymerase (an enzyme essential for initiating gene transcription) 
from binding; and 2) methyl-CpG-binding domain proteins translocate binding to 
methylated CpGs and subsequently recruit transcriptional silencing complexes, such as 
histone deacetylase, resulting in chromatin condensation and consequently repressed gene 
transcription (Crider et al., 2012; Klose & Bird, 2006; Lillycrop et al. 2005; Yan et al., 
2013). DNA methylation is a reversible process, thus, demethylation (removal of a 
methyl group) can up-regulate gene expression by relaxing chromatin to activate gene 
transcription (Chmurzynska, 2010; Crider et al., 2012). 
ii) Folic Acid and DNA Methylation  
Lillycrop et al. (2005) showed rat offspring of mothers fed a protein-restricted diet 
(containing 1 mg folic acid/kg diet) during pregnancy and lactation, expressed lower 
levels of methylation and higher expression of the peroxisome proliferator-activated 
receptor (PPARα) and glucocorticoid receptor (GR) genes in the liver. Supplementation 
of a protein-restricted diet with supplemental folic acid (5 mg folic acid/kg diet) negated 
hypomethylation of PPARα and GR genes. Moreover, a similar phenomenon has been 
shown in the agouti (Avy) mouse model. The Avy gene locus is responsible for pigment 
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colouration of hair follicles, thus, epigenetic variation of the Avy locus results in a wide 
variation of coat colours (Chmurzynska, 2010). Hypomethylation of the Avy gene locus 
results in overexpression of the gene consequently producing a yellow coat (agouti 
phenotype), as well as, a tendency towards obesity, whereas, hypermethylation of the 
gene produces a brown coat (pseudoagouti phenotype) (Cooney et al., 2002). Maternal 
methyl-supplemented diets, containing folic acid (5mg folic acid/kg diet), betanine, 
vitamin B12, and choline, during pregnancy and lactation, increased hypermethylation at 
seven Avy pseudoexon 1A sites and the prevalence of pseudoagouti phenotype, while 
subsequently lowering obesity in offspring agouti mice at 3 weeks of age (Cooney et al., 
2002; Waterland & Jirtle, 2003; Wolff et al., 1998). A follow-up study compared the 
effects of maternal dietary supplementation (4.3mg folic acid/kg diet) on DNA 
methylation in bisphenol A-treated agouti mice exhibiting hypomethylation at 9 CpG 
sites upstream of the Avy pseudoexon promoter (Dolinoy et al., 2007) Maternal 
supplementation with folic acid counteracted the DNA hypomethylating effect of 
bisphenol A, restoring the pseudoagouti phenotype (Dolinoy et al., 2007). Together, these 
studies indicate maternal dietary methyl donors have strong effects on DNA methylation 
and phenotype of offspring, which may affect long-term health.  
DNA methylation, through methyl donors, such as folic acid, is thought to affect 
the commitment of mesenchymal stem cells to a myogenic lineage during the 
developmental process (Yan et al., 2013). However, the mechanisms underlying methyl 
supplementation and gene modification have yet to be fully elucidated in response to 
maternal diet, specifically in regard to skeletal muscle development. To our knowledge, 
there are no studies related to folic acid supplementation and skeletal muscle, however, a 
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study examined the effects of maternal folic acid deficiency on skeletal muscle offspring 
in a swine model (Li et al., 2013). Muscle fibre size and number was reduced in folic acid 
deficient piglets. Furthermore, folic acid deficiency impacted muscle gene transcription 
and expression, extensively down-regulating lipid-metabolism related genes and 
associated metabolic pathways, such as glucose and protein metabolism, in offspring (Li 
et al., 2013). This provides evidence that folic acid undernutrition affects the skeletal 
muscle transcriptome of offspring, which may be through epigenetic alterations.  
1.4. Food Folate and Supplemental Folic Acid 
1.4.1 Dietary Sources  
Folate is present in a variety of food sources at varying amounts. The main dietary 
sources of folate are liver, dark green leafy vegetables (spinach, broccoli, asparagus), 
legumes (beans and chickpeas), citrus fruits (oranges), fermented dairy products (yogurt, 
cheese, milk), and yeast (Table 1.2) (Blancquaert et al., 2010; Finglas, 2003; Iyer & 
Tomar, 2009; Lucock, 2000; Winkels et al., 2007). Furthermore, breads, pastas, and 
breakfast cereals fortified with folic acid provide a significant contribution to the diet 
(Finglas, 2003; Winkels et al., 2007). Breakfast consisting of two medium eggs (~75 µg), 
1 piece of toast (~100 µg), 1 medium banana (~25 µg) and 1 cup of orange juice (~100 
µg) will provide approximately 250 µg of folic acid (Table 1.2). Lunch consisting of a 
salad with 1 cup of spinach (~300 µg), 1 avocado (~150 µg), 8 strawberries (~100 µg), 
and ½ cup of chickpeas (~200 µg) will provide approximately 750 µg of folic acid (Table 
1.2). Lastly, dinner consisting of 1 cup of pasta (~200 µg) with ½ a cup of broccoli (~100 
µg) and a side Caesar salad with ½ a cup of romaine lettuce (~50 µg) will provide 
approximately 350 µg of folic acid (Table 1.2). Thus, pregnant and lactating woman can 
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consume approximately 3-4 times (1800-2400 µg) the RDA of folic acid through daily 
dietary intake (~1350 µg) and supplemental use (400-1000 µg) (Table 1.3).  
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Table 1.2 Food folate content of common foods from the Canadian Nutrient File, 2010. 
 
Food Source Serving Size Folate (µg) (DFE) 
Vegetables   
Edemame/soybeans, cooked 125 mL (½ cup) 255 
Spinich, cooked 125 mL (½ cup) 139 
Asparagus, cooked 6 spears 139 
Broccoli, cooked 125 mL (½ cup) 89 
Brussels sprouts, cooked 4 sprouts 85 
Lettuce (Romaine) 250 mL (1 cup) 80 
Potato, white, with skin, baked 1 medium 66 
Fruits   
Avacado ½ fruit 81 
Orange Juice 125 mL (½ cup) 58 
Orange  1 fruit 48 
Grain Products†   
Pasta, egg noodles, enriched, cooked 125 mL (½ cup) 138 
Pasta, white, enriched, cooked 125 mL (½ cup) 113 
Bread, white 1 slice 106 
Instant cereal, hot, oats 250 mL (1 cup) 87 
Muffin, oat bran ½ muffin 79 
Meat and Alternatives   
Liver (lamb), cooked 75 g (2½ oz) 300 
Lentils, cooked  175 mL (¾ cup) 265 
Chickpeas, cooked  175 mL (¾ cup) 209 
Beans, kidney, cooked  175 mL (¾ cup) 170 
Beans, navy, cooked  175 mL (¾ cup) 146 
Milk and Alternatives   
Eggs 2 large 76 
Cheese, brie* 50 g (1.7oz) 32 
Yogurt, plain* 175 mL (¾ cup) 21 
Milk 2%* 250 mL (1 cup) 13 
Other   
Yeast extract spread (vegemite or 
marmite) 
30 mL (2 Tbsp) 371 
µg: micrograms; DFE: Dietary Folate Equivalents 
* Folate level increases if fermented (Iyer & Tomar, 2009) 
† Fortified food products may contain higher folate content than reported (Shakur et al., 
2009) 
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1.4.2 Absorption  
 
After consumption, food folates (polyglutamates) are hydrolyzed by the brush 
border of the mucosal cells in the stomach to the monoglutamate form, via folate 
conjugase (Halsted, 1991; Institute of Medicine, 1998; Wright et al., 2007). 
Monoglutamates are absorbed by reduced folate carriers or proton-coupled folate 
transporters in the mucosal cells of the jejunum (proximal small intestine) (Guéant et al., 
2013; Visentin et al., 2014; Zhao, Matherly & Goldman, 2009). At concentrations below 
280 µg, monoglutamates are absorbed by an active pH-dependent process, however, at 
concentrations above 280 µg, monoglutamates can be absorbed by a passive diffusion 
process, indicating folic acid uptake is saturable (Finglas, 2003; Kelly et al., 1997; Wright 
et al., 2007). Prior to entry into the hepatic portal vein, folic acid is reduced to 
tetrahydrofolate (THF) and subsequently methylated to 5-methyltetrahydrofolate (5-
methyl-THF) (Kelly et al., 1997; Scott, 1999; Wright et al., 2007). The liver removes a 
large amount of folic acid from the hepatic blood circulation before it enters the systemic 
plasma circulation. The liver either stores the folic acid, approximately 50% of total 
folate is stored in the liver, or it is released in the bile where it enters the enterohepatic 
cycle to be recirculated (Finglas, 2003; Lucock, 2000; Wright et al., 2007). The primary 
form of folic acid found in the systemic circulation is 5-methyl-THF, however, if 
pharmacological amounts (>280 µg) of folic acid are ingested, unmetabolized folic acid 
may also be present in circulation (Finglas, 2003; Kelly et al., 1997). Circulating folic 
acid is then transported to peripheral tissues by folate transport systems to be used for 
various functions, discussed previously (Section 1.3.1 Function of Folate).   
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1.4.3 Bioavailability 
Bioavailability is defined as the proportion of an ingested nutrient that is absorbed 
and can be used for metabolic processes (Blancquaert et al., 2010; Winkels et al., 2007). 
Multiple factors play a role in the bioavailability of folates, such as folate structure and 
physiological influences. Naturally occurring food folates, such as polyglutamates, have a 
bioavailability of approximately 50% (Institute of Medicine, 1998; Lindzon & O’Connor, 
2007; Winkels et al., 2007). This may be due to the additional hydrolysis step necessary 
for polyglutamates prior to absorption. Moreover, studies have shown individuals with a 
less active form of folate conjugase have a lower folate status than those with higher 
folate conjugase activity (Devlin et al., 2000; Gregory, 2001). 
When consumed alone, supplemental folic acid has a bioavailability of 100%, 
however, when consumed with food the bioavailability decreases to approximately 85%.  
Absorption of monoglutamates are dependent on intestinal pH levels, which can be 
altered by various foods or drugs, however, little is known regarding nutritional 
interactions that affect folate bioavailability (Gregory, 2001; Tamura & Stokstad, 1973). 
Moreover, evidence has shown active absorption is maximized at a pH of 6.3 and rapidly 
declines between pH 6.3 and 7.6 (Finglas, 2003; Russell et al., 1979).  
1.4.4 Recommended Daily Requirements 
Erythrocyte folate is an indicator of the long-term status of folate and is reflective 
of tissue folate stores, whereas, plasma homocysteine levels are indicative of the amount 
folate present in the blood to donate methyl groups for the conversion of homocysteine to 
methionine (Institute of Medicine, 1998). Taken together, erythrocyte folate and plasma 
homocysteine biomarkers were used to determine the Recommended Dietary Allowance 
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(RDA) of folic acid. The adequate intake (AI) of folic acid is determined from the 
observed average intake of infants exclusively fed human milk (Institute of Medicine, 
1998) (Table 1.3). 
i) General Recommendations for Adults 
The current RDA of folate intake for adults is 400 µg/day of dietary folate 
equivalents (DFE) (Table 1.3) (Institute of Medicine, 1998). DFEs adjust for the lower 
bioavailability of naturally occurring folate compared to folic acid found in fortified 
foods and supplements, which will be discussed later (Section 1.4.3 Absorption). One 
DFE is equivalent to 1 µg of food folate, 0.6 µg of folic acid fortified food, and 0.5 µg of 
folic acid consumed on an empty stomach (Institute of Medicine, 1998). The Tolerable 
Upper Intake Level (UL) of folate (folic acid only) is 1000 µg/day for adults (Institute of 
Medicine, 1998).  
ii) Recommendations for Pregnancy 
The RDA for pregnant and lactating woman is 600 and 500 µg/day, respectively 
(Institute of Medicine, 1998) (Table 1.3). To reduce the risk of neural tube defects at birth, 
Health Canada recommends all women take a daily prenatal folic acid supplement 
containing 400 µg of folic acid, in addition to their dietary folate intake, three months 
prior to pregnancy and throughout the pregnancy (De Wals et al., 2007; Health Canada, 
2009; Ray, 2004). Moreover, the Society of Obstetricians and Gynaecologists of Canada 
recommends woman with an increased risk for neural tube defects, characterized by a 
family or personal history of neural tube defects or folate sensitive abnormalities, take a 
daily prenatal folic acid supplement containing 1000 µg of folic acid in addition to their 
dietary folate intake (SOGC Clinical Practice Guideline, 2015). Additionally, in 1998, 
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folic acid fortification (150 - 200 µg/100g) of all white flour, enriched pasta and cornmeal 
products became mandatory in Canada to reduce the risk of neural tube defects at birth 
(De Wals et al., 2007; Lindzon & O’Connor, 2007; Ray, 2004; Shakur et al., 2009; 
Wright et al., 2007). The Flour Fortification Policy was estimated to increase an 
individual’s dietary folate intake by a minimum of 100 µg/day (Jägerstad, 2012; Ray, 
2004; Shakur et al., 2009). After flour fortification was implemented, the prevalence rate 
of neural tube defects at birth decreased by approximately 50% in Canada (Castillo-
Lancellotti et al., 2013; De Wals et al., 2007; Jägerstad, 2012). Furthermore, the 
prevalence of folate inadequacy among the Canadian population remains low (<20%) 
since mandatory folic acid fortification (Shakur et al., 2010). Moreover, with the 
prevalent use of prenatal supplements, pregnant woman in Canada have high maternal 
folate concentrations of 2400 and 2800 nmol/L during early pregnancy and delivery, 
respectively (Plumptre et al., 2015). Additionally, unmetabolized folic acid is detectable 
in >90% of maternal blood due to the high level of supplemental folic acid intake 
(Plumptre et al., 2015). High maternal folate concentrations may affect the long-term 
health outcomes of offspring, such as skeletal muscle function and metabolism, thus, 
further investigation is warranted due to the mandatory folic acid fortification and 
prevalent supplemental use due to Health Canada’s current recommendations for woman 
of childbearing age.  
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Table 1.3 Recommended dietary allowance (RDA) of folate by age group (Adapted from 
Health Canada, 2010). 
 
Age µg/day (DFE) 
Birth to 6 months 65* 
7-12 months 80* 
1-3 years 150 
4-8 years 200 
9-13 years 300 
14+ years 400 
Pregnancy 600 
Lactation 500 
   *Adequate Intake (AI) 
 µg: micrograms; DFE: Dietary Folate Equivalents 
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1.5. Statement of the Problem 
 
Skeletal muscle is an important contractile and metabolic tissue essential for 
locomotion and cellular energy metabolism. Evidence suggests maternal nutrition, such 
as high-fat diets, protein restriction, methyl supplemented diets, and folic acid deficiency 
diets, during pregnancy and lactation can cause epigenetic alterations of the fetal genome, 
affecting the long-term growth and development of offspring skeletal muscle (Cooney et 
al., 2002; Langley-Evans, 2009; Li et al., 2013; Waterland & Jirtle, 2003; Wolff et al., 
1998; Wu et al., 2004; Zeng et al., 2013). Maternal overnutrition in animal models, due to 
high fat diets, during pregnancy and lactation have shown impaired skeletal muscle 
contractile and metabolic properties, characterized by reduced twitch and tetanic tension, 
glucose and fatty acid metabolism, and cellular respiration rates, affecting overall muscle 
function in offspring at 12 weeks of age (Bayol et al., 2005; Claycombe et al., 2015; 
Walter & Klaus, 2014). There is evidence maternal methyl-supplemented diets, such as 
folic acid supplementation, during pregnancy and lactation, modulate DNA methylation 
and phenotype of offspring (Cooney et al., 2002; Dolinoy et al., 2007; Lillycrop et al., 
2005; Waterland & Jirtle, 2003; Wolff et al., 1998).   Additionally, maternal folate 
deficiency results in significant down-regulation of carbohydrate (HK) and lipid (CPT1) 
metabolism gene expression in male offspring, as indicated through gene chip analysis 
(Li et al., 2013).   
However, there is limited information regarding the influence of maternal 
supplemental folic acid diet on offspring skeletal muscle growth and development, 
characterized by contractile and metabolic function, through nutritional programming. 
Additionally, sex-specific responses to methyl-supplemented diets on skeletal muscle 
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function and metabolism has not been studied. Thus, the purpose of this thesis was to 
examine if supplemental folic acid from preconception through lactation programs 
skeletal muscle function in male and female offspring at adulthood by 1) examining 
twitch characteristics of representative slow (SOL) and fast (EDL) twitch muscles and 2) 
measuring maximal enzyme activities of carbohydrate and lipid metabolism. 
 
  
	  	  
	   	   	  44	  
1.6. Objectives 
 
The overall objective of this study was to determine if maternal supplemental 
folic acid diet, throughout pregnancy and lactation, programs skeletal muscle tissue 
function and metabolism in male and female offspring. The specific objectives of this 
study were to determine if adult offspring (at 6 months of age) exposed to maternal 
supplemental folic acid diet throughout pregnancy and lactation had differences in: 
 
1) Contractile function characterized by peak twitch tension, peak tetanic tension, 
half-relaxation time, peak time to relaxation, twitch-to-tetanus ratio, rate of force 
development and rate of relaxation, in SOL and EDL muscle and; 
 
2) Metabolic function measured by carbohydrate (hexokinase; HK and 
phosphofructokinase; PFK), lipid (carnitine palmitoyltransferase; CPT and 3-
Hydroxyacyl-CoA dehydrogenase; β-HAD), and oxidative (citrate synthase; CS 
and cytochrome C oxidase; COX) regulators in EDL and SOL muscle tissue. 
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1.7. Hypothesis 
 
Six-month-old male and female offspring exposed to maternal supplemental folic 
acid diet, in utero and during suckling, compared to recommended folic acid diet will 
have:  
 
1) Increased contractile function reflected by a greater peak twitch and tetanic 
tension, faster half-relaxation time and peak time to relaxation, a higher twitch-to-
tetanus ratio, and a faster rate of force development and rate of relaxation, in SOL 
and EDL muscle. 
 
2) Higher metabolic enzyme activity measured by greater HK, PFK, CPT, β-HAD, 
CS and COX activity in EDL and SOL muscle tissue. 	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CHAPTER 2.0 – METHODS 
2.1. Animals and Diet 
This study was a subset of a larger study looking at the influence of maternal folic 
acid supplemented diet on offspring skeletal health. Briefly, at 2, 4, and 6 months of age, 
the right hindlimb of a subset of mice and the abdominal region of an additional subset of 
mice was irradiated to assess bone structure and body composition, respectively, using 
micro-computed tomography. For that reason, skeletal muscle contractile outcomes were 
assessed in the left hindlimb, as it was not irradiated during the study. This avoided any 
potential effects due to irradiation. Skeletal muscle enzyme activity outcomes were 
assessed in both the left and right hindlimbs of mice used to assess body composition, as 
muscles were not irradiated during the study. To allow for time involved with 
longitudinal scans of the hindlimb, mice were studied in three consecutive batches. Each 
batch of mice received the same treatment throughout the study, and was approximately 
equal size (Figure 3.1 & 3.2). Sample sizes for each group (CON & FA) and outcome 
(contractile & enzymatic activity) varied due to death of offspring at birth, during 
scanning procedures, or for unknown reasons over the period of the study. Additionally, 
some force traces during contractile function were lost due to technological issues. All 
experimental procedures complied with the Canadian Council on Animal Care and were 
approved by the Brock University Animal Care Committee (Olfert et al., 1993). 
Female CD-1 mice (n=31) were obtained from Charles River Laboratories (Saint-
Constant, Quebec, Canada) at 5 weeks of age and housed 4-5 per cage at 22 ± 1°C with a 
12:12 h light-dark cycle. Mice were housed in groups to provide environmental 
enrichment, since mice are social animals that benefit from interactions, and enhance 
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their overall well-being (Olfert et al., 1993). After a 5-day adaptation period, mice were 
randomized to receive control (CON; modified AIN93G diet, 2 mg folic acid/kg diet; 
n=15) or supplemented folic acid (FA; modified AIN93G diet, 8 mg folic acid/kg diet; 
n=16) diet. Mice were given access to food and water ad libitum. The AIN93G diet is a 
‘healthy’ diet specifically used in nutritional science research to support the nutritional 
needs of growing, pregnant and lactating rodents (Reeves, Nielsen & Fahey, 1993). The 
CON diet was modified with alcohol-extracted ‘vitamin-free’ casein. This was done to 
ensure any naturally occurring folic acid present in casein was removed so any observed 
effects in offspring could be attributed to the known higher quantity of folic acid in the 
diet, and not due to the intake of additional nutrients. The amount of folic acid in the 
CON diet (2 mg/kg diet) was to represent the basal dietary requirements for growing, 
lactating and/or pregnant rodents. The FA diet was identical to the CON diet except it 
contained a higher level (8 mg/kg diet) of folic acid (Table A.1). The purpose of 
increasing folic acid in the diet to 4 times higher than the CON diet was to mimic the 
amount of folic acid pregnant and lactating mothers consume through folic acid 
fortification and prenatal supplement use (Health Canada, 2009). Diets were isocaloric 
with 19.4% energy from protein, 63.8% energy from carbohydrate, and 16.7% energy 
from fat (TD.06706 & TD.140396; Harlan Teklad, Missisauga, ON). 
Food intake was determined by weighing, recording and subtracting the amount 
of food remaining from the previous feeding. The total food intake per cage was then 
divided by the number of days since the last recording, and the number of mice in the 
cage, to provide an estimated daily food consumption for each mouse. Food intake and 
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body weight was recorded biweekly and weekly, respectively (Denver Instrument Scale, 
MXX-5, Bohemia, NY, USA). 
2.2. Experimental Design 
 
At 10 weeks of age, female mice were mated harem-style with male CD-1 mice 
(n=14) of similar age (Figure 2.1). Male mice were obtained from Charles River 
Laboratories at 9 weeks of age and housed singly prior to breeding. Male mice were fed 
CON diet and water, ad libitum, prior to mating, when they were switched to the female’s 
respective diets (CON or FA) (Figure 2.1). Each male mouse was bred with two females 
from each intervention group, with the exception of one male bred with three females 
(CON), to ensure equal paternal influence among groups. Once pregnancy was confirmed 
(~1 week), determined by an increase in body weight greater than normal weekly weight 
gain, the female mice were housed singly until delivery, remaining on their respective 
diets throughout pregnancy (~3 weeks) and lactation (3 weeks). Offspring remained with 
the mother until weaning on postnatal day (PND) 21. Litter weights were recorded on 
PND 9, 16, and 21 (Denver Instrument, MXX-5, Bohemia, NY, USA).  
At PND 21, offspring were weaned to CON diet and housed 5 per cage, per 
gender (Figure 2.1). Because there were often more than 5 females and 5 males per litter, 
offspring that were followed to adulthood were selected according to their body weight at 
weaning. Specifically, 5 female and 5 male offspring with median body weights, within 
the range of body weights per gender, per litter, were selected. The offspring were 
subsequently ear tagged to ensure proper identification of each animal throughout the 
study. Food intake was recorded biweekly, while body weight was recorded once weekly 
for the duration of the study.  
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At 6 months of age, offspring were euthanized after an overnight fast. Only one 
offspring per litter, per gender was reported, representing an n=1for each outcome, to 
ensure the results were not biased due to over-representation of each litter (“litter effect”; 
Wainwright, 1998). One mouse per gender was used for in vitro skeletal muscle 
contractile experiments using the left hindlimb (discussed next) and two mice per litter, 
per gender were pooled using both hindlimbs for enzyme assays (Figure 2.1).  
The mice were anaesthetized using isoflurane gas inhalant (3-5% delivery rate) 
until an adequate depth of anaesthesia, confirmed by the absence of the withdraw reflex 
to a toe-pinch, was reached. Soleus (SOL; 31% type I, 49% type IIa, 12% type IId/x, 3% 
type IIb) and extensor digitorum longus (EDL; <1% type I, 10% type IIa, 24% type IId/x, 
56% type IIb) (Bloemberg & Quadrilatero, 2012) were surgically removed from both 
hindlimbs, immediately frozen in liquid nitrogen and stored at -80°C until further 
analysis. The mice were euthanized via exsanguination.  	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Figure 2.1. Flow chart of the experimental design. CON, control diet; EDL, extensor 
digitorum longus; SOL, soleus; M, male; F, female (Saint, 2016).   
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2.3. In Vitro Muscle Preparation 
 2.3.1 Muscle Isolation 
Once mice were under adequate depth of anaesthesia, the skin of the lower 
hindlimb was gently peeled back to expose the musculature of interest. The EDL and 
SOL were surgically removed from the left hindlimb once both proximal and distal 
tendons were secured with suture. To accomplish this, the distal tibialis anterior tendon 
was cut to expose the distal tendons of the EDL, which extend along the metatarsals. The 
tibialis anterior muscle was dissected away to uncover the EDL muscle underneath. 
Distal to the myotendon junction, the EDL tendon was secured using a non-absorbable 
braided 4-0 silk suture. A small incision lateral to the knee was made to the biceps 
femoris muscle to expose the proximal tendon of the EDL, which was then lashed with 
suture and the muscle removed by cutting the tendon proximal to the suture. 
To remove the SOL muscle, the distal Achilles tendon was cut from the calcaneus 
and the triceps surae muscles were peeled back away from the tibia. The SOL muscle was 
located on the underside of the gastrocnemius muscle and separated from the posterior 
compartment muscles using blunt scissors. At the distal myotendon junction of the SOL 
(attached to the Achilles tendon), sutures were tied and the tendon was cut inferior to the 
suture knot. The proximal tendon of the SOL, located on the posterior surface of the tibia, 
was sutured and cut superior to the suture knot prior to removal of the muscle. Isolated 
muscles were initially left to equilibrate under slight tension in a resting bath for 30 
minutes that contained cooled (4-5 °C) and oxygenated Tyrode’s solution to ensure 
viability until required (MacPherson et al., 2013).  
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2.3.2 Mounting Muscles to the Apparatus 
From each animal, EDL and SOL were mounted into separate experimental 
apparatus (1200a In Vitro Muscle Testing System, Aurora Scientific Inc.). Muscles were 
mounted to the dual-mode servomotor (Model 305B) by clamping the distal tendon to the 
fixed electrode assembly and lashing the proximal tendon to the lever arm of the 
servomotor via a hooked non-compliant stainless steel wire. The muscles were suspended 
in a jacketed organ bath containing oxygenated (95% O2 and 5% CO2) Tyrode’s solution 
maintained at 25.0 ± 0.1 °C with a pH of approximately 7.4 (Lännergren et al., 2000). 
Tyrode’s solution is a physiological saline solution that approximates the physiological 
conditions of the muscle in vivo and provides the essential substrates necessary for cell 
metabolism and muscle contraction. The composition of the buffered solution (in mM) 
was: 121 NaCl; 5 KCl; 24 NaHCO3; 0.4 NaH2PO4; 0.5 MgCl2; 1.8 CaCl2; 5.5 D-glucose; 
and 0.1 EDTA. During brief and/or intermittent stimulation (i.e. low duty cycle), viability 
of intact EDL and SOL muscles can be maintained at 25 °C due to adequate  oxygen 
diffusion, thus, the Tyrode’s solution was maintained at this temperature (Barclay, 2005). 
The muscles were stimulated using flanking platinum electrodes driven by a Model 701B 
biphase stimulator (Aurora Scientific Inc.). Data acquisition was performed using Aurora 
Scientific Inc. 600a software (Version 1.60). All contractile experiments for each muscle 
type were collected from the same apparatus to ensure there was no additional variability 
introduced between samples.  
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2.4. Isometric Contractile Experiment Protocol 
 2.4.1 Determination of Supramaximal Stimulus Conditions 
Once mounted, left EDL and SOL were briefly stimulated supramaximally at 150 
Hz to remove any possible compliance in the suture/tendon connection before subsequent 
experimental procedures. Complete muscle recruitment was ensured by setting the 
current of the stimulation above the threshold required to achieve maximal twitch force.  
Once supramaximal stimulus conditions were established, the muscles were left to return 
to baseline conditions (MacPherson et al., 2013). 
2.4.2 Determination of Optimal Length 
Optimal length (Lo) was defined as the muscle length at which peak twitch force 
was produced. Following the equilibrium period, Lo was determined by stimulating the 
muscle at various resting tensions (MacPherson et al., 2013). Initially, the resting tension 
of the muscle was removed and stimulated by a single electrical pulse (1 Hz) to elicit a 
twitch response. Resting tension was subsequently increased at 1.0 mN intervals while a 
single stimulus was applied at each length. The muscle length at which maximal active 
twitch force (total force – passive force) was reached was determined as Lo. Muscle 
length (Lo) was measured visually between the myotendon junctions using digital Vernier 
calipers (SOL) and a horizontal stereo zoom microscope (EDL) and was used as the 
reference length for all subsequent procedures.  
2.4.3 Peak Twitch and Peak Tetanus Force 
At Lo, a single stimulation pulse was applied to the muscle to produce a maximal 
twitch response (forces measured in mN). Additionally, TPT and ½ RT were calculated 
(in ms) from the force-time trace. TPT was calculated from the time the twitch 
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contraction began to the time peak tension was produced. ½ RT was calculated from the 
time it takes to the muscle to reach 50% of peak tension from the time peak tension was 
produced. +dP/dt and –dP/dt were measured by taking the maximal positive and negative 
slopes, respectively, over a 17-point consecutive spread, from the differentiated force-
time trace. Subsequently, peak tetanic force (Po) was determined by brief (500 ms) 
supramaximal stimulation (150 Hz for EDL and 100 Hz for SOL) (MacPherson et al., 
2013). The twitch:tetanus ratio (Pt:Po) was later calculated from the two force amplitudes. 
2.4.4 Specific Tension Calculation 
To control for variations in cross sectional area (CSA) between each muscle, 
muscle forces were normalized to CSA. The CSA for each muscle was determined by 
dividing the mass of the muscle (g) by the product of its optimum fibre length (Lf) and 
density of mammalian muscle (1.06 mg/mm3) (Equation 2.1) (Liu et al., 2005; Mendez & 
Keys, 1960). Lf was calculated by multiplying Lo by the fibre length to muscle length 
ratio previously reported for each muscle type: 0.44 for EDL and 0.71 for SOL (Brooks 
& Faulkner, 1988). Next, Pt and Po were divided by muscle CSA to obtain normalized 
peak twitch and tetanic forces (Equation 2.2). 
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𝐶𝑆𝐴  (𝑚𝑚!) =    𝑀𝑢𝑠𝑐𝑙𝑒  𝑚𝑎𝑠𝑠  (𝑔)  (𝐿!  ×  1.06  𝑚𝑔/𝑚𝑚!) 
 
Equation 2.1.  Cross sectional area equation. 
 
 
 
 
 
 
𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐  𝑡𝑒𝑛𝑠𝑖𝑜𝑛  (𝑔/𝑚𝑚!) =   𝑃𝑒𝑎𝑘  𝑡𝑒𝑡𝑎𝑛𝑖𝑐  𝑜𝑟  𝑡𝑤𝑖𝑡𝑐ℎ  𝑓𝑜𝑟𝑐𝑒  (𝑛𝑀)𝐶𝑆𝐴  (𝑚𝑚!)  
 
Equation 2.2.  Specific twitch and tetanic force equation. 
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2.5. Metabolic Enzyme Assays 
  
2.5.1 Muscle Tissue Preparation 
 
Whole muscle tissue of EDL and SOL was weighed (~18mg) and added to a pre-
chilled 2mL glass homogenizer containing homogenization buffer (50 mM Tris-HCL; pH 
7.8) to a final concentration of 20:1 (v/w).  The sample was homogenized using glass-on-
glass manual homogenization. All metabolic enzyme activities were measured using an 
Ultraspec 2100 Pro spectrophotometer (Biochrom, Cambridge, UK) at 25 ± 1oC.  
2.5.2 Enzyme Activity 
i) Hexokinase 
Carbohydrate metabolism was measured by hexokinase (HK; EC 2.7.1.1) activity 
as previously outlined by Thompson & Cooney (2000) with the following modifications. 
The reaction buffer included 40 mM triethanolamine-HCl (pH 7.6), 5 mM EDTA, 7.5 
mM MgCl2, 0.42 mM NADP, 2.5 mM ATP, 10 µg (1.67 U/mL) glucose-6-phosphate 
dehydrogenase, 2.22 mM D(+)-glucose, and 50 µL homogenate. The reaction was 
initiated by the addition of D(+)-glucose. The appearance of NADPH was used to 
determine HK activity at 340 nM (millimolar extinction coefficient: ε340=6.22). 
ii) Phosphofructokinase 
Phosphofructokinase (PFK; EC 2.7.1.11) activity was measured to determine 
carbohydrate metabolism. The details of the assay were previously described by 
Passonneau & Lowry (1993) with the following modifications. The reaction buffer 
contained 38.3 mM Tris-Base (pH 8.0), 2 mM MgCl2, 10 mM K2HPO4, 0.375 mM 
NADH, 1 mM 5’-AMP, 2 U/mL α-glycerophosphate dehydrogenase, 62.4 U/mL 
triosephosphate isomerase, 1.61 U/mL aldolase, 1 mM ATP, 2.5 mM fructose-6-
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phosphate, and 10 µL homogenate. The addition of fructose-6-phosphate initiated the 
reaction. Activity was measured by the change in absorbance of NADH to NAD+ at 
340nm (millimolar extinction coefficient: ε340=6.22). 
iii) Carnitine Palmitoyltransferase 
Lipid metabolism was measured by carnitine palmitoyltransferase (CPT; EC 
2.3.1.21) activity as previously described by Bieber et al. (1972) with the following 
modifications. The reaction buffer contained 76.6 mM Tris-HCl (pH 8.0), 1.1 mM EDTA, 
0.24mM DTNB, 0.08 mM palmitoyl-CoA, 1.1 mM L-carnitine, and 15 µL of 
homogenate. Additionally, the homogenate was subjected to three freeze-thaw cycles to 
ensure mitochondrial membrane ruptured. The enzyme reaction rates were determined by 
measuring change in absorbance of DTNB to TNB at 412 nm (millimolar extinction 
coefficient: ε412=13.6). 
iv) 3-Hydroxyacyl-CoA Dehydrogenase 
β-oxidation of fatty acids was measured by 3-Hydroxyacyl-CoA dehydrogenase 
(β-HAD; EC 1.1.1.35) activity as previously described by Bass et al., (1969) with the 
following modifications. The reaction buffer contained 103.2 mM triethanolamine-HCL, 
5 mM EDTA, 0.225 mM NADH, 0.1 mM acetoacetyl-CoA, and 20 µL of homogenate. 
The reaction was initiated with the addition of acetoacetyl-CoA. The enzyme reaction 
rates were determined by the change in absorbance of NADH to NAD+ at 340 nm 
(millimolar extinction coefficient: ε340=6.22). 
v) Citrate Synthase 
Citrate synthase (CS; EC 2.3.3.1) activity was used as a marker to measure the 
presence of intact mitochondria as per Srere (1969) with the following modifications. The 
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reaction buffer contained 0.1 mM DTNB, 0.5 mM acetyl-CoA, 0.5% Triton X-100, 0.5 
mM oxaloacetate, and 2.5 µL of homogenate. Additionally, three freeze-thaw cycles were 
performed to the homogenate to ensure rupture of the mitochondrial membrane. Addition 
of oxaloacetate initiated the reaction. Change in absorbance of DTNB to TNB at 412 nM 
determined CS activity (millimolar extinction coefficient: ε412=13.6) 
vi) Cytochrome C Oxidase 
Mitochondrial respiratory capacity was measured via cytochrome c oxidase 
(COX; EC 1.9.3.1) activity as previously described (Cooperstein & Lazarow, 1950), with 
the following modifications. The reaction buffer contained 18.3 mM phosphate buffer 
(pH 7.4), 3.0% Tween 20, 0.04 mM cytochrome c, and 10 µL of homogenate. The 
homogenate underwent three freeze-thaw cycles to ensure mitochondrial membrane was 
ruptured. Addition of cytochrome C initiated the reaction. Enzymatic rates were 
determined at 550 nm (millimolar extinction coefficient:  ε550=21.84). 
2.6. Statistical Analysis 
All values are expressed as means ± standard errors (SEM). Male and females 
were examined separately for all analysis. For offspring, repeated measures two-way 
ANOVA, followed by a Tukey post-hoc analysis was used to analyze body weight, with 
offspring ages and maternal diet (CON and FA) used as the two factors. Independent 
sample t-tests were conduced to establish differences between diet (CON and FA) in 
muscle function characteristics (Pt, Po, ½ RT, TPT, Pt:Po, +dP/dt, -dP/dt), as well as, 
metabolic enzyme activities (HK, PFK, CPT, β-HAD, CS and COX) for male and female 
offspring. Additionally, contractile function data was normalized to peak twitch force and 
independent sample t-tests were conduced to establish differences between diet (CON 
	  	  
	   	   	  59	  
and FA) in muscle function characteristics. Statistical significance was determined at p ≤ 
0.05. All statistical analyses were performed using IBM SPSS Statistics (version 23, 
SPSS INC, Chicago, IL). 
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CHAPTER 3.0 – RESULTS 
 
3.1. Body Weight  
At 6 months of age, final body weights of the folic acid group did not differ from 
controls within males (Figure 3.1) and females (Figure 3.2). There were no diet or diet x 
time interaction effects on body weight throughout the duration of the study in male or 
female mice (Figure 3.1 and Figure 3.2). As expected, there was an effect of time 
(p<0.001) as the mice were growing (Figure 3.1 and Figure 3.2). Additionally, final body 
weights of male and females did not differ between groups when mice were separated 
based on outcome (contractile function or metabolic activity) at 6 months of age (data not 
shown). 
3.2. Anthropometric Muscle Properties 
In both male and female mice, EDL mass (mg), length (mm) and CSA (cm2) did 
not significantly differ between control and folic acid groups (Table 3.1; Table 3.2). In 
males, SOL length and mass did not differ from controls for the folic acid group, 
however, CSA in the folic acid group significantly decreased by 10% (p<0.05; Table 3.1). 
In females, SOL mass and CSA were similar between diets but muscle length 
significantly decreased by ~3% (p<0.05) with folic acid compared to controls (Table 3.2). 
3.3. Isometric Contractile Function 
Representative twitch force traces for the control and folic acid diets are presented 
in Figure 3.3 and Figure 3.4 for both males and females, respectively. Force traces that 
were closest to the average twitch parameters across each group were chosen to be 
representative force traces. In males, the isometric contractile characteristics for EDL and 
SOL did not significantly differ between control and folic acid groups (Table 3.3; Figure 
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3.3). In female mice, the groups did not differ in EDL and SOL, with the exception of 
increased TPT (15%) in SOL and decreased ½ RT (25%) and –dP/dt (28%) in EDL of the 
folic acid group (Table 3.4; Figure 3.4). 
3.4. Maximal Enzyme Activity 
 
In males, CS and HK activity increased by 24% and 13% (p<0.05) in SOL and 
EDL, respectively (Table 3.5; Figure 3.5; Figure 3.6). In female mice, with the exception 
of significantly decreased HK activity in the FA group by ~12% (p<0.05) compared to 
controls in the SOL, there was no effect on maximal enzyme activities (Table 3.6; Figure 
3.7; Figure 3.8). 
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Figure 3.1. Body weight in grams of male offspring. Values are mean ± SEM. CON, 
n=24 (n=10 for contractile function; n=14 for enzymatic activity); FA, n=28 (n=8 for 
contractile function; n=20 for enzymatic activity). CON, 2mg folic acid/kg diet; FA, 8mg 
folic acid/kg diet. 
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Figure 3.2. Body weight in grams of female offspring. Values are mean ± SEM. CON, 
n=29 (n=9 for contractile function; n=20 for enzymatic activity); FA, n=28 (n=8 for 
contractile function; n=20 for enzymatic activity). CON, 2mg folic acid/kg diet; FA, 8mg 
folic acid/kg diet. 
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Table 3.1. Effect of a supplemental folic acid diet on male offspring CD-1 mice soleus 
(SOL) and extensor digitorum longus (EDL) muscle properties.  
 
 CON FA 
SOL   
Mass (mg) 13.6 ± 0.7 12.7 ± 0.4 
Length (mm) 13.3 ± 0.2  13.5 ± 0.1 
CSA (mm2) 1.38 ± 0.05 1.25 ± 0.03* 
EDL   
Mass (mg) 14.2 ± 0.5 14.0 ± 0.4 
Length (mm) 13.6 ± 0.2 13.8 ± 0.2 
CSA (mm2) 2.24 ± 0.07 2.19 ± 0.07 
Values are mean ± SEM. CON, n=9; FA, n=7; * Significantly different from CON. CON, 
2mg folic acid/kg diet; FA, 8mg folic acid/kg diet; SOL, soleus; EDL, extensor digitorum 
longus; CSA, cross-sectional area.  
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Table 3.2. Effect of a supplemental folic acid diet on female offspring CD-1 mice soleus 
(SOL) and extensor digitorum longus (EDL) muscle properties.  
 
 CON FA 
SOL   
Mass (mg) 12.2 ± 0.5 12.1 ± 0.6 
Length (mm) 13.4 ± 0.2 13.0 ± 0.1* 
CSA (mm2) 1.21 ± 0.06 1.24 ± 0.06 
EDL   
Mass (mg) 12.3 ± 0.4 12.0 ± 0.5 
Length (mm) 13.8 ± 0.1 13.3 ± 0.2 
CSA (mm2) 1.91 ± 0.05 1.93 ± 0.09 
Values are mean ± SEM. CON, n=9; FA, n=8; * Significantly different from CON. CON, 
2mg folic acid/kg diet; FA, 8mg folic acid/kg diet; SOL, soleus; EDL, extensor digitorum 
longus; CSA, cross-sectional area.  
 
  
	  	  
	   	   	  66	  
Table 3.3. Effect of a supplemental folic acid diet on male offspring CD-1 mice soleus 
(SOL) and extensor digitorum longus (EDL) muscle isometric contractile function.  
 
 CON FA 
SOL   
Pt (mN) 32 ± 3 32 ± 2 
Po (mN) 229 ± 19 224 ± 18 
Pt/CSA (mN/cm2) 2.3 ± 0.1 2.8 ± 0.2 
Po/CSA (mN/cm2) 16.5 ± 1.1 17.9 ± 1.2 
Pt:Po 0.142 ± 0.002 0.157 ± 0.013 
TPT (ms) 41.2 ± 2.3 44.8 ± 3.3 
½ RT (ms) 51.8 ± 6.1 56.8 ± 7.5 
+dP/dt (mN/ms) 1.80 ± 0.17 2.03 ± 0.09 
-dP/dt (mN/ms) 0.49 ± 0.09 0.54 ± 0.07 
EDL   
Pt (mN) 84 ± 9 93 ± 5 
Po (mN) 463 ± 27 459 ± 21 
Pt/CSA (mN/cm2) 3.7 ± 0.3 4.2 ± 0.2 
Po/CSA (mN/cm2) 20.6 ± 0.7 20.9 ± 0.6 
Pt:Po 0.179 ± 0.012 0.204 ± 0.014 
TPT (ms) 18.6 ± 0.4 18.2 ± 0.4 
½ RT (ms) 21.4 ± 1.6 22.1 ± 1.0 
+dP/dt (mN/ms) 7.27 ± 0.78 8.04 ± 0.52 
-dP/dt (mN/ms) 3.37 ± 0.40 3.75 ± 0.25 
Values are mean ± SEM. CON, n=7; FA, n=9; CON, 2mg folic acid/kg diet; FA, 8mg 
folic acid/kg diet; SOL, soleus; EDL, extensor digitorum longus; Pt, peak twitch force; Po, 
peak tetanic force; CSA, cross-sectional area; Pt:Po, twitch to tetanus ratio; TPT, time-to-
peak tension; ½ RT, half relaxation time; +dP/dt, rate of contraction; -dP/dt, rate of 
relaxation.  
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Figure 3.3. Representative isometric peak twitch force trace of male mice extensor 
digitorum longus and soleus muscles from control and folic acid groups. EDL, extensor 
digitorum longus; SOL, soleus; CON, 2mg folic acid/kg diet; FA, 8mg folic acid/kg diet. 
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Table 3.4. Effect of a supplemental folic acid diet on female offspring CD-1 mice soleus 
(SOL) and extensor digitorum longus (EDL) muscle isometric contractile function.  
 
 CON FA 
SOL   
Pt (mN) 33 ± 2 30 ± 4 
Po (mN) 242 ± 14 199 ± 25 
Pt/CSA (mN/cm2) 2.6 ± 0.2 2.4 ± 0.2 
Po/CSA (mN/cm2) 18.9 ± 1.5 15.8 ± 1.5 
Pt:Po 0.149 ± 0.01 0.156 ± 0.01 
TPT (ms) 40.8 ± 0.9 46.9 ± 2.3* 
½ RT (ms) 49.0 ± 2.9 52.1 ± 1.6 
+dP/dt (mN/ms) 1.74 ± 0.13 1.44 ± 0.17 
-dP/dt (mN/ms) 0.47 ± 0.04 0.44 ± 0.05 
EDL   
Pt (mN) 74 ± 4 73 ± 8 
Po (mN) 388 ± 23 340 ± 33 
Pt/CSA (mN/cm2) 3.9 ± 0.1 3.8 ± 0.4 
Po/CSA (mN/cm2) 20.2 ± 0.8 17.5 ± 1.3 
Pt:Po 0.193 ± 0.007 0.217 ± 0.020 
TPT (ms) 18.3 ± 0.3 18.5 ± 0.5 
½ RT (ms) 24.1 ± 1.2 18.1 ± 0.7* 
+dP/dt (mN/ms) 6.41 ± 0.37 6.16 ± 0.73 
-dP/dt (mN/ms) 2.23 ± 0.15 3.09 ± 0.38* 
Values are mean ± SEM. CON, n=9; FA, n=8; * denotes significance CON; CON, 2mg 
folic acid/kg diet; FA, 8mg folic acid/kg diet; SOL, soleus; EDL, extensor digitorum 
longus; Pt, peak twitch force; Po, peak tetanic force; CSA, cross-sectional area; Pt:Po, 
twitch to tetanus ratio; TPT, time-to-peak tension; ½ RT, half relaxation time; +dP/dt, 
rate of contraction; -dP/dt, rate of relaxation.  
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Figure 3.4. Representative isometric peak twitch force trace of female mice extensor 
digitorum longus and soleus muscles from control and folic acid groups. EDL, extensor 
digitorum longus; SOL, soleus; CON, 2mg folic acid/kg diet; FA, 8mg folic acid/kg diet. 
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Table 3.5. Effect of a supplemental folic acid diet on male offspring CD-1 mice soleus 
and extensor digitorum longus muscle maximal enzyme activity (µmol/min/g of wet wt. 
tissue).  
 
 CON FA 
SOL   
Carbohydrate   
HK 5.6 ± 0.2 6.1 ± 0.2 
PFK 27.2 ± 0.6 27.8 ± 1.1 
Lipid   
CPT 0.67 ± 0.09 0.84 ± 0.22 
β-HAD 26.9 ± 1.2 26.9 ± 1.7 
Oxidative   
CS 30.5 ± 2.3 37.7 ± 2.5* 
COX 37.3 ± 4.7 34.4 ± 3.0 
EDL   
Carbohydrate   
HK 3.4 ± 0.1 3.9 ± 0.2* 
PFK 44.5 ± 1.2 47.2 ± 1.2 
Lipid   
CPT 0.26 ± 0.05 0.49 ± 0.12 
β-HAD 11.0 ± 0.9 13.6 ± 1.1 
Oxidative   
CS 24.1 ± 1.8 22.7 ± 1.4 
COX 31.8 ± 3.5 26.5 ± 3.8 
Values are mean ± SEM. n = 10; CON, 2mg folic acid/kg diet; FA, 8mg folic acid/kg 
diet; SOL, soleus; EDL, extensor digitorum longus; HK, hexokinase; PFK, 
phosphofructokinase; CPT, carnitine palmitoyltransferase; β-HAD, 3-hydroxyacyl-CoA 
dehydrogenase; CS, citrate synthase; COX, cytochrome c oxidase.  
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Figure 3.5. Relative change in maximal enzyme activity in male mice soleus (SOL) 
muscles. Values are mean ± SEM. n = 10; * Significantly different from CON. CON, 
2mg folic acid/kg diet; FA, 8mg folic acid/kg diet; HK, hexokinase; PFK, 
phosphofructokinase; β-HAD, β-hydroxyacyl-CoA dehydrogenase; CPT, carnitine 
palmitoyltransferase; CS, citrate synthase; COX, cytochrome c oxidase. 
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Figure 3.6. Relative change in maximal enzyme activity in male mice extensor digitorum 
longus (EDL) muscles. Values are mean ± SEM. n = 10; * Significantly different from 
CON. CON, 2mg folic acid/kg diet; FA, 8mg folic acid/kg diet; HK, hexokinase; PFK, 
phosphofructokinase; β-HAD, β-hydroxyacyl-CoA dehydrogenase; CPT, carnitine 
palmitoyltransferase; CS, citrate synthase; COX, cytochrome c oxidase. 
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Table 3.6. Effect of a supplemental folic acid diet on female offspring CD-1 mice soleus 
(SOL) and extensor digitorum longus (EDL) muscle maximal enzyme activity 
(µmol/min/g of wet wt. tissue).  
 
 CON FA 
SOL   
Carbohydrate   
HK 5.0 ± 0.1 4.4 ± 0.2* 
PFK 20.4 ± 0.8 19.0 ± 0.7 
Lipid   
CPT 0.90 ± 0.09 0.77 ± 0.13 
β-HAD 12.9 ± 0.9 11.4  ± 0.4 
Oxidative   
CS 21.1 ± 1.0 19.6 ± 0.8 
COX 29.0 ± 1.1 28.9 ± 0.9 
EDL   
Carbohydrate   
HK 2.9 ± 0.1 3.0 ± 0.1 
PFK 46.5 ± 2.6 47.2 ± 1.7 
Lipid   
CPT 0.34 ± 0.04 0.44 ± 0.05 
β-HAD 5.0 ± 0.3 5.1  ± 0.4 
Oxidative   
CS 19.9 ± 0.7 17.4 ± 1.3 
COX 26.7 ± 1.1 28.2 ± 1.3 
Values are mean ± SEM. n = 10; CON, 2mg folic acid/kg diet; FA, 8mg folic acid/kg 
diet; SOL, soleus; EDL, extensor digitorum longus; HK, hexokinase; PFK, 
phosphofructokinase; CPT, carnitine palmitoyltransferase; β-HAD, 3-hydroxyacyl-CoA 
dehydrogenase; CS, citrate synthase; COX, cytochrome c oxidase.  
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Figure 3.7. Relative change in maximal enzyme activity in female mice soleus (SOL) 
muscles. Values are mean ± SEM. n = 10; * Significantly different from CON. CON, 
2mg folic acid/kg diet; FA, 8mg folic acid/kg diet; HK, hexokinase; PFK, 
phosphofructokinase; β-HAD, β-hydroxyacyl-CoA dehydrogenase; CPT, carnitine 
palmitoyltransferase; CS, citrate synthase; COX, cytochrome c oxidase. 
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Figure 3.8. Relative change in maximal enzyme activity (µmol/min/g of wet wt. tissue) 
in female mice extensor digitorum longus (EDL) muscles. Values are mean ± SEM. n = 
10; CON, 2mg folic acid/kg diet; FA, 8mg folic acid/kg diet; HK, hexokinase; PFK, 
phosphofructokinase; β-HAD, β-hydroxyacyl-CoA dehydrogenase; CPT, carnitine 
palmitoyltransferase; CS, citrate synthase; COX, cytochrome c oxidase. 
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CHAPTER 4.0 – DISCUSSION 
 
The present study investigated the effect of maternal exposure to supplemental 
folic acid diet (4 times higher than normal dietary levels), from preconception through 
lactation, on muscle function and metabolism in male and female CD-1 mice. Folic acid 
is a methyl donor that affects DNA methylation and is important in the relationship 
between maternal nutrition and fetal growth and development. A study examining the 
effects of maternal folic acid deficiency on skeletal muscle offspring in swine model 
found lipid-metabolism related genes were down-regulated through gene chip analysis 
(Li et al., 2013). However, to our knowledge this is the first study to examine the long-
term effects of early life exposure to maternal folic acid supplementation on offspring 
muscle function and metabolism. The major results of this study were that exposure to 
folic acid 1) increased TPT in SOL and decreased ½ RT and –dP/dt in EDL in females 
with no contractile differences seen in males; 2) decreased HK activity in the SOL among 
females; and 3) increased HK activity and CS activity in the EDL and SOL, respectively, 
in males. 
4.1. Males  
 4.1.1 Isometric Contractile Function 
Maternal folic acid supplementation had no impact on male offspring SOL mass, 
length or contractile function compared to controls. Furthermore, there was no difference 
between offspring EDL mass, length, cross-sectional area (CSA) or contractile function 
between groups. However, male offspring SOL CSA, after exposure to maternal folate 
supplementation, was reduced by ~10% compared to controls. At 6 months of age, body 
weight did not differ between groups, thus, the smaller muscle CSA seen in the folic acid 
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group is likely not due to overall body weight. In contrast, the decrease in SOL CSA is 
nearly proportional to the overall smaller mass (~8%) seen in the folic acid group 
compared to controls. Although the difference of SOL mass was not statistically 
significant (p=0.3) between groups (potentially due to an underpowered sample size (ex. 
n=8-10/group; power = 0.52 versus a sufficient 0.80)), the differences seen in CSA may 
be attributed to this. A sample size of 19 per group would be needed for a power of 0.8. 
Skeletal muscle mass is determined by the number and size of individual muscle 
fibres (Frontera & Ochala, 2015). The formation of new muscle fibres (myogenesis) 
occurs prenatally, whereas, postnatal skeletal muscle development occurs due to an 
increase in muscle fibre size (Yan et al., 2013). Thus, prenatal development of muscle 
fibres plays a critical role on the overall growth and development of adult skeletal muscle. 
DNA methylation, through methyl donors, such as folic acid, is thought to affect the 
commitment of mesenchymal stem cells to a myogenic lineage during the developmental 
process (Yan et al., 2013). Myogenic differentiation factor D (MyoD) plays a major role 
in regulating muscle differentiation. MyoD binds monocyte enhancer factor 2 (MEF2), a 
transcription factor expressed in oxidative tissues essential for oxidative metabolism, to 
metabolic genes increasing gene expression for myogenesis (McGee & Hargreaves, 
2010; Zheng et al., 2010). Hypermethylation of histone residues suppresses the 
transcriptional activity of MyoD and MEF2, in turn inhibiting myogenesis (McGee & 
Hargreaves, 2010; Yahi et al., 2006). In contrast, hypomethylation of histone residues 
promotes transcriptional activity, initiating myogenesis (Yahi et al., 2006). Thus, the 
decrease in SOL CSA from maternal supplemental levels of folic acid may be explained 
by the inhibition of offspring skeletal muscle myogenesis during prenatal development 
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due the suppression of MyoD and MEF2. Furthermore, SOL may have been impacted by 
the high maternal levels of folic acid more than EDL because MEF2 is mainly expressed 
in oxidative tissues and SOL muscle expresses a higher percentage of oxidative type I 
fibres (~31%) compared to EDL (<1%) (Bloemberg & Quadrilatero, 2012).  
Previous research has shown protein restriction throughout gestation reduced 
body weight and muscle mass in rat offspring at weaning (Desai et al., 1996). Moreover, 
protein restriction through cross-fostering immediately after birth showed a similar effect 
on offspring body weight and muscle mass at weaning (Desai et al., 1996), indicating 
early life exposure to nutritional insults can greatly affect postnatal skeletal muscle 
development. In rodents, changes in fibre type and myosin heavy chain (MHC) isoform 
composition of skeletal muscle occur during early postnatal development. In early life, 
fast twitch fibre types, such as EDL, progressively accumulate MHCII isoforms (IIa, 
IId/x, & IIb), whereas, slow twitch fibre types (SOL) progressively transform type IIa 
fibres into type I fibres (Schiaffino & Reggiani, 201l). Overall, type II muscle fibres are 
larger in size with a higher glycolytic capacity compared to oxidative type I fibres 
(Haizlip et al., 2015). Therefore, the differences in male offspring SOL CSA between the 
two groups may be attributed to a shift in fibre types toward smaller, oxidative type I 
fibres that occur during early life exposure to maternal supplemental folic acid. However, 
previous research has shown type II fibres are more susceptible to nutritional insults 
resulting in greater atrophy and fibre loss compared to slow twitch oxidative fibres 
(Matsakas & Patel, 2009). Thus, the 10% decrease in SOL CSA may be due to a loss of 
larger glycolytic type II fibres, rather than a switch in fibre types. Future research should 
examine other hindlimb muscles with variant fibre type compositions, such as plantaris 
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(<1% type I, 19% type IIa, 22% type IId/x, 47% type IIb) or tibialis anterior (1% type I, 
18% type IIa, 45% type IId/x, 25% type IIb) muscles (Bloemberg & Quadrilatero, 2012), 
to confirm these findings.  
4.1.2 Maximal Enzyme Activity 
 
Maternal folic acid supplementation did little to alter the metabolic activity in 
SOL and EDL muscles among male offspring with the exception of CS and HK, 
respectively. The maximal activity of CS in SOL muscles increased by 24%, whereas, the 
maximal activity of EDL HK increased by 13% in male offspring exposed to a 
supplemental folic acid diet in utero and during early life compared to control. Previous 
studies have shown that hypermethylation results in decreased expression of energy 
producing genes, such as PGC-1α, CPT and HK, in turn decreasing lipid and 
carbohydrate metabolism in mice cardiac muscle (Czubryt et al., 2003; McGee & 
Hargreaves, 2010). Moreover, PGC-1α expression is silenced by DNA hypermethylation 
in skeletal muscle of female offspring exposed to a maternal low protein diet (Zeng et al., 
2013). PGC-1α stimulates mitochondrial biogenesis, regulates skeletal muscle fibre type 
determination (promoting more oxidative type 1 fibres), and regulates carbohydrate and 
lipid metabolism, playing a significant role in the regulation of energy metabolism (Liang 
& Ward, 2006).  
In contrast to previous research, the current study found offspring SOL CS 
maximal activity significantly increased when exposed to a maternal supplemental folic 
acid diet, which may be due to discrepancies in the literature. For example, although 
hypermethylation occurs with a maternal low protein diet and supplemental levels of folic 
acid, it is possible each nutrient may have varying effects on gene expression (Czubryt et 
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al., 2003; McGee & Hargreaves, 2010; Zeng et al., 2013). Additionally, responses to 
DNA methylation may vary between the different types of muscle tissues examined (ex. 
cardiac vs. skeletal muscle), as each muscle type has a unique function. Lastly, sex-
specific epigenetic differences may occur since over 3,000 genes are differentially 
expressed between male and female skeletal muscle (Welle et al., 2008).  
 Additionally, maximal activity of EDL HK significantly increased in offspring 
exposed to a maternal supplemental folic acid diet. HK is a key protein involved in 
carbohydrate metabolism and glucose uptake. Zheng et al. (2012) found in utero maternal 
protein restriction results in methylation at the GLUT4 promotor region increasing 
GLUT4 expression, as well as, regulatory genes associated with carbohydrate metabolism 
(ex. MEF2) in skeletal muscle tissue of female offspring. GLUT4 is a transporter protein 
that plays a critical role in regulating glucose homeostasis through glucose uptake (Huang 
& Czech, 2007). Thus, the findings from the current study, in regards to EDL HK activity, 
are similar to that of Zheng et al. (2012), however, comparisons being made should be 
done with caution. As mentioned previously, discrepancies between the current studies 
findings and the literature are the gender of the rodent and the dietary interventions used. 
HK and CS are mediators at the beginning of the glycolytic and TCA cycle, respectively, 
therefore, changes in subsequent metabolic markers may not have been seen due to a 
potential homeostatic regulation of these pathways.   
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4.2. Females  
4.2.1 Isometric Contractile Function 
i) SOL 
Female offspring SOL length was 3% less with maternal folic acid 
supplementation compared to controls. However, there was no differences seen between 
SOL mass or CSA. Additionally, exposure to maternal folic acid supplementation 
resulted in a ~15% increase in time-to-peak tension in SOL compared to control. 
Conversely, time-to-peak tension (TPT) was no longer statistically significant when 
twitch kinetics were normalized to force produced, however, rate of force development 
(+dP/dt) significantly decreased by 10% in the folic acid group compared to control 
(Table A.3).  
The smaller length seen in the folic acid group is likely not attributed to biological 
significance, as mass and CSA is a larger indicator of force production (Matsakas & Patel, 
2009). Thus, a potential explanation for the differences in contractile function could be 
due to a shift in fibre type composition or another mechanism, such as SERCA (discussed 
further in detail). Slow twitch fibres are characterized by a longer TPT and slower +dP/dt 
compared to fast twitch fibres (Schiaffino & Reggiani, 2011). Additionally, TPT and 
shortening velocity decreases in female rat SOL as type II fibres progressively transform 
into type I fibres during the first 3 months of life (Close, 1964). Thus, the findings from 
this study could be indicative of a switch to a greater proportion of type I oxidative fibres 
from type II glycolytic fibres in male and female SOL muscles. 
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ii) EDL 
Maternal folic acid supplementation had no impact on offspring EDL mass, length 
or CSA compared to controls among females. In contrast, exposure to maternal folic acid 
supplementation resulted in a 25% increase in half-relaxation time (½ RT) and 28% 
increase in maximal rate of relaxation (-dP/dt) in offspring EDL compared to control. 
Furthermore, when normalizing the twitch kinetics to force produced, ½ RT was not 
statistically significant but statistical differences seen with -dP/dt persisted (Table A.3).  
A shorter ½ RT and more rapid –dP/dt are indicative of a greater proportion of 
fast twitch glycolytic fibres (Schiaffino & Reggiani, 201l), thus, EDL appears to be 
impacted differently than the SOL among females. However, these differences could be 
explained due to the differential developmental rates of muscles during gestation as 
previous research has shown nutritional interventions affects all muscles differently 
(Matsakas & Patel, 2009). Moreover, type II fibres appear to be more susceptible to 
nutritional insults. Undernutrition results in greater fibre loss and atrophy of type II 
muscle fibres, however, it is unknown how overnutrition affects each fibre type 
(Matsakas & Patel, 2009). Given that mouse EDL is predominately composed of type II 
fibres (~90%), it is possible the high levels of maternal folic acid may have impacted type 
II fibres in EDL, in turn, impacting the contractile properties of the muscle.  
Additionally, there are multiple isoforms of type II muscle fibres in mice (IIa, 
IIx/d, IIb). EDL contains more type IId/x (24%) and type IIb (56%) fibres, whereas, SOL 
is predominately type IIa (49%) (Bloemberg & Quadrilatero, 2012), thus, the differential 
response to maternal supplemental folic acid between EDL and SOL may be explained by 
the differences of type II isoform composition. As mentioned previously, future research 
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should examine additional mice hindlimb muscles with different fibre type compositions 
(ex. plantaris and tibialis anterior) to further understand these findings.  
4.2.2 Maximal Enzyme Activity 
i) SOL 
Maternal folic acid supplementation did little to alter the metabolic activity in 
SOL muscles among female offspring with the exception of HK. The maximal activity of 
HK in offspring SOL muscles that were exposed to a supplemental folic acid diet in utero 
and during early life exposure decreased by 12% compared to control. Previous studies 
have shown that hypermethylation results in decreased expression of PGC-1α, CPT and 
HK, in turn decreasing lipid and carbohydrate metabolism in mice cardiac muscle 
(Czubryt et al., 2003; McGee & Hargreaves, 2010). In contrast, a study found in utero 
maternal protein restriction resulted in increased GLUT4 expression, as well as, 
regulatory genes associated with carbohydrate metabolism in skeletal muscle tissue of 
female offspring (Zheng et al., 2012). Thus, there are discrepancies in the literature in 
regards to hypermethylation and its effect on metabolic markers in muscle tissue, due to 
the nutritional intervention used and the type of muscle tissue examined.  
TPT and +dP/dt increased in SOL muscles among females, indicating a potential 
shift in fibre type composition to more oxidative slow twitch fibres, thus the decrease in 
maximal HK activity could be due to a decrease in fast twitch glycolytic muscle fibres, as 
HK plays a key role in glycolysis. However, metabolic markers of lipid and oxidative 
metabolism showed no significant influence from supplemental levels of folic acid, 
therefore, it is difficult to determine the biological significance of these findings with no 
changes in other skeletal muscle metabolic markers.  
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ii) EDL 
Although there were differences seen in ½ RT and -dP/dt between groups in the 
EDL, maternal folic acid supplementation did not alter the metabolic activity in offspring 
EDL muscles among females. This may suggest alternate pathways are being utilized for 
the changes seen in the contractile data, such as sarco(endo)plasmic reticulum Ca2+-
ATPase (SERCA). SERCA’s main function is to facilitate muscle relaxation by pumping 
calcium ions from the cytosol into the SR lumen which re-establishes calcium 
homeostasis necessary for muscle contraction (Periasamy & Kalyanasunaram, 2007). 
Moreover, SERCA’s function can be characterized by its activity and efficiency. SERCA 
activity is measured by the amount of calcium translocated per unit of time, whereas, 
SERCA efficiency is measured by the ratio of calcium ions transferred per hydrolyzed 
ATP (Lervik et al, 2012; Periasamy & Kalyanasunaram, 2007). Although SERCA can 
bind up to two calcium ions per ATP molecule, previous studies have calculated 
SERCA’s efficiency to be only 12% (Lervik et al, 2012), since the ratio of calcium ions 
transferred per hydrolyzed ATP, varies under physiological conditions. This is a result of 
calcium slippage (calcium released prematurely) or calcium leakage due to the 
concentration of calcium in the SR lumen being too high (Reis et al, 2001; Yu & Inesi, 
1995).  
In adult skeletal muscle, two main isoforms of SERCA are expressed that are 
muscle and fibre type specific: SERCA1a and SERCA2a (Periasamy & 
Kalyanasundaram, 2007). SERCA1a is expressed with type II MHC isoforms (IIa, IId/x, 
and IIb) in fast twitch muscles (ex. EDL), whereas, SERCA2a is predominately found 
with type I MHC isoforms in slow twitch muscles, such as the SOL (Fajardo et al., 2013; 
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Periasamy & Kalyanasundaram, 2007). Fast twitch muscle fibres produce quick, 
repetitive contraction cycles, thus, SERCA1a is present at a greater density and displays a 
higher ATPase activity, compared to SERCA2a, to ensure calcium is sequestered rapidly 
(Murphy et al., 2009; Szentesi et al, 2001). In contrast, SERCA2a displays decreased 
calcium leakage compared to SERCA1a in fatigued skeletal muscles, which helps to 
maintain fatigue resistance in slow twitch muscle fibres (Macdonald & Stephenson, 
2006). Furthermore, similar to skeletal muscle fibres, SERCA isoforms are highly plastic 
and can switch during development (Periasamy & Kalyanasundaram, 2007). However, 
the regulatory processes initiating SERCA isoform switches is not understood, thus, 
future research should aim to quantify SERCA and measure SERCA maximal activity in 
mice offspring skeletal muscle exposed to a maternal supplemental folic acid diet to 
further explain these findings.  
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4.3. Conclusion 
 
 In summary, this study was the first to examine the effects of a maternal 
supplemental folic acid diet, from preconception through lactation, on offspring skeletal 
muscle function and metabolism. Our findings suggest sex-specific differences of 
offspring skeletal muscle contractile function and metabolism to a maternal supplemented 
folic acid diet may occur. Contractile function was affected in female, but not male 
offspring, which may be attributed to shifts in fibre types. Furthermore, EDL and SOL 
muscles were affected differently in female offspring. SOL appeared to become even 
more slow twitch, characterized by a longer TPT and +dP/dt, whereas, the opposite 
occurred in the EDL, becoming more fast twitch, characterized by a more rapid ½ RT and 
–dP/dt. Additionally, carbohydrate metabolic markers (HK) significantly decreased in the 
SOL in the folic acid group, whereas, there were no significant differences seen in 
metabolic markers in the EDL among females. Moreover, in the males, oxidative markers 
(CS) increased in the SOL, whereas, carbohydrate metabolic markers (HK) increased in 
the EDL in the folic acid groups. Therefore, future research is necessary to understand the 
mechanisms associated with maternal supplemental levels of folic acid and how it affects 
male and female offspring skeletal muscle at young adulthood.  
4.4. Implications of Research 
In 1998, folic acid fortification of all white flour, enriched pasta and cornmeal 
products became mandatory in Canada to reduce the risk of neural tube defects at birth. 
Additionally, Health Canada recommends all women take a daily prenatal folic acid 
supplement containing 400 µg of folic acid, in addition to their dietary folate intake, three 
months prior to pregnancy and throughout the pregnancy (De Wals et al., 2007; Health 
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Canada, 2009; Ray, 2004). Moreover, the Society of Obstetricians and Gynaecologists of 
Canada recommends women with an increased risk for neural tube defects take a daily 
prenatal folic acid supplement containing 1000 µg of folic acid (SOGC Clinical Practice 
Guideline, 2015). The current RDA for pregnant and lactating woman is 600 µg/day and 
500 µg/day, respectively (Institute of Medicine, 1998). Thus, mandatory folic acid 
fortification and prevalent supplemental use due to Health Canada’s current 
recommendations for women of child-bearing age, results in pregnant women being 
exposed to 4 times higher folic acid during pregnancy.  
Folic acid is a methyl donor that affects DNA expression and is important in the 
relationship between maternal nutrition and fetal growth and development, therefore, 
high maternal folate concentrations may affect the long-term health outcomes of 
offspring, such as skeletal muscle function and metabolism. Based on the findings of this 
study, skeletal muscle function and metabolism is affected by in utero and early exposure 
to supplemental levels of folic acid, with sex-specific differences. This research will 
provide further insight into the impact of high maternal folate concentrations on the long-
term health and development of exposed offspring, which is important due to the lack of 
evidence on offspring skeletal muscle function and metabolism in the literature and the 
increased levels of maternal consumption. A previous study has shown high multivitamin 
intake (10-fold increase in folic acid) during pregnancy results in increased expression of 
an obesogenic phenotype in male and female rat offspring (Szeto et al., 2009), thus, 
although the findings from this study do not show detrimental implications on offspring 
skeletal muscle function and metabolism from a maternal supplemental folic acid diet in 
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rodents at adulthood, future studies in human populations are necessary to confirm high 
levels of maternal folic acid intake are not detrimental to the offspring. 
4.5. Strengths and Limitations 
 
4.5.1 Strengths 
This research is novel in that, to our knowledge, it is the first to examine the 
impact of a maternal folic acid diet on offspring skeletal muscle function and metabolism 
into adulthood. A previous study has looked at the effects of maternal folic acid 
deficiency on skeletal muscle offspring in a swine model (Li et al., 2013), however, the 
long-term effects of offspring skeletal muscle into adulthood, from exposure to 
supplemental levels of folic acid in utero or in early life has not been studied. Due to the 
prevalent use of supplements and mandatory folic acid fortification in Canada, it is 
important to understand the long-term health effects of folic acid on various tissues in 
adulthood. Moreover, this research is the first to investigate a wide array of maximal 
enzyme activities in skeletal muscle tissue representing key enzymes of carbohydrate, 
lipid and oxidative metabolism as a result of a maternal supplemental folic acid diet. With 
this information we are able to examine a variety of metabolic pathways that may be 
altered in offspring due to high maternal levels of folic acid. 
There are several strengths associated with the design of the study, such as the 
duration of the study. Previous research in bone has shown CD-1 mice reach young 
adulthood becoming fully developed at 4 months of age (Ward et al., 2007). Additionally, 
skeletal muscle tissue has fully developed in rodents by 3 months of age (Close, 1964). 
Thus, 6 months of age ensures the mice are fully developed but are not yet showing 
“aging” effects (Brooks & Faulkner, 1988). It is important species are fully developed, 
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surpassing the growth and developmental stages, to truly detect a nutritional 
programming effect. Measuring the outcomes at 6 months of age allowed for examination 
of the sustained effects of a maternal supplemental diet on offspring skeletal muscle into 
adulthood. Another strength of the study design, was that only one offspring per litter, per 
gender was reported for each outcome to ensure the results were not biased due to over-
representation of each litter (“litter effect”; Wainwright, 1998). It is expected individual 
offspring within each litter are more similar to one another then offspring from another 
litter, thus, studying only one offspring per litter removes any potential bias and 
appropriately represents each dam randomized to the control or folic acid diets.  
A major strength of this study was the chosen diets. The folic acid diet was 
identical to the control diet (2 mg folic acid/kg diet) except it contained a higher level of 
folic acid (8 mg folic acid/kg diet). The amount of folic acid in the control diet was to 
represent the basal dietary requirements for growing, pregnant and/or lactating rodents. 
The purpose of increasing folic acid in the diet to 4 times higher was to mimic the amount 
of folic acid pregnant and lactating mothers consume through folic acid fortification and 
prenatal supplement use (Health Canada, 2009). Additionally, the diets were modified 
with alcohol-extracted ‘vitamin-free’ casein to ensure any naturally occurring folic acid 
present within the protein was removed. Overall, this guaranteed that any observed effect 
on offspring skeletal muscle was truly attributed to increased levels of folic acid 
consumption, and not due to the intake of additional nutrients.  
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4.5.2 Limitations  
A limitation of the study was the small sample size. The primary outcome of this 
study was skeletal muscle contraction. The current study was underpowered (~0.5 vs a 
sufficient 0.8). In order to obtain a power of 0.8 for the primary outcome of contractile 
function, 19 mice per group were necessary, however, due to the logistics of the current 
study, this was not feasible. A smaller sample size can show significant differences that 
are not seen with larger sample sizes of sufficient power. Thus, the results from this study 
should be interpreted with caution.  
Another limitation of the study was that the mice (dams) were housed 4-5 per 
cage up until pregnancy was confirmed. From a social and ethical perspective this is 
considered a strength in order to enhance the animals overall well-being (Olfert et al., 
1993). Housing multiple animals together may result in less accurate food intake 
measurements for each individual dam, however, there were no differences seen in body 
weight between groups suggesting this did not contribute to differences seen in offspring 
skeletal muscle function and metabolism at young adulthood. Additionally, maternal and 
offspring blood concentrations of folate were not collected during pregnancy or lactation 
to determine folate status. Previous studies have found women who consume 
supplemental levels of folic acid (1000 µg) during pregnancy and lactation, in addition to 
their dietary intake, have significantly higher blood folate concentrations during 
pregnancy and at birth, as well as, higher milk folate concentrations postpartum 
compared to nonusers (Mackey & Picciano, 1999; Plumptre et al., 2015). Moreover, 
umbilical cord blood from woman taking folic acid supplements during late pregnancy 
resulted in significantly higher blood folate concentrations compared to those who were 
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not (Plumptre et al., 2015). Thus, knowing the levels of folate concentrations in maternal 
circulation, in utero and during early life exposure, may help to understand the levels of 
folic acid associated with long-term skeletal muscle health outcomes of offspring. Future 
research should aim to replicate this study quantifying blood concentrations of folate in 
mothers during pregnancy and lactation and offspring at birth and throughout suckling.  
 Secondly, fibre typing was not measured directly. It is known skeletal muscle is a 
highly adaptable tissue that responds to environmental and physiological stimuli, such as 
nutritional status, by shifting fibre type composition (Matsakas & Patel, 2009). Therefore, 
it can be speculated the effects seen from a maternal supplemental folic acid diet on 
offspring skeletal muscle contractile function could be attributed to shifts in fibre types. 
Additionally, slack tests or fatigue indices were not conducted which would have been a 
good surrogate to determine potential shifts in fibre types, as faster fibre types are 
associated with faster shortening velocities (Edman, 1979).  
Lastly, no mechanisms were examined. DNA methylation, through methyl donors 
such as folic acid, influences many genes critical to offspring skeletal muscle 
development. The mechanisms underlying methyl supplementation and gene 
modification have yet to be fully elucidated in response to maternal diet in skeletal 
muscle. Understanding the potential pathways of DNA methylation on skeletal muscle 
tissue could help determine whether changes in contractile function was due to signalling 
of metabolic pathways or as a result of the utilization of different pathways, such as Ca2+ 
signalling via SERCA.  
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4.6. Future Research 
Future research should aim to identify the underlying biological pathways and 
mechanisms affected by methyl-donor supplementation, such as folic acid, during 
pregnancy and lactation on offspring skeletal muscle tissue. Previous research has found 
folate deficiency during pregnancy and lactation resulted in significant down regulation 
of carbohydrate and lipid metabolism genes through the peroxisome proliferator-activated 
receptor (PPAR) signalling pathway of skeletal muscle in male swine offspring (Li et al., 
2013). Additionally, maternal methyl-donor deficiency has been shown to impair fatty 
acid oxidation through decreased expression of PPAR-α and PGC-1α of cardiac tissue in 
rat offspring (Guéant et al., 2013). In contrast, overexpression of PPAR-α has been 
shown to be involved in increased lipid metabolism and reduced glucose metabolism, 
whereas, PGC-1α stimulates mitochondrial biogenesis and regulates muscle fibre type 
determination (promoting oxidative type I fibres) and fatty acid oxidation in rodent 
skeletal muscle fibres (Burri et al., 2010; Guéant et al., 2013; Matsakas & Patel, 2009). 
Thus, in elucidating these mechanisms, it is essential to understand how skeletal muscle 
tissue is altered by in utero and early life exposure to maternal supplemental folic acid. 
Additionally, SERCA is an alternate pathway that may be utilized to explain the 
differences seen in the contractile data. SERCA’s main function is to facilitate muscle 
relaxation by pumping calcium ions from the cytosol into the SR lumen, which is 
necessary for muscle contraction (Periasamy & Kalyanasunaram, 2007). In adult skeletal 
muscle, two main isoforms of SERCA are expressed that are fibre type specific: 
SERCA1a and SERCA2a (Periasamy & Kalyanasundaram, 2007). Although the structure 
is similar between the two isoforms, they are functionally different due to their co-
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expression with different MHC isoforms. For example, SERCA1a is expressed with fast 
type II MHC isoforms (IIa, IId/x, and IIb), whereas, SERCA2a is predominately found 
with slow type I MHC isoforms (Fajardo et al., 2013; Periasamy & Kalyanasundaram, 
2007). Additionally, SERCA1a is typically present at greater densities displaying higher 
ATPase activity, compared to SERCA2a. Thus, future research should aim to quantify 
SERCA via Western blots and measure SERCA maximal activity in mice offspring 
skeletal muscle exposed to a maternal supplemental folic acid diet to further explain these 
findings. 
Also, future research should characterize skeletal muscle fibre types in offspring 
exposed to a maternal supplemental folic acid diet compared to control-fed rodents in 
utero and during early life exposure. Skeletal muscle displays high plasticity due to the 
adaptive changes of muscle fibres in response to a variety of stimuli, including diet 
(Matsakas & Patel, 2009). Thus, methyl donors, such as folic acid, may alter the fibre 
type composition of various skeletal muscle tissue, consequently affecting contractile 
function and metabolism. Additionally, a variety of muscle types, such as soleus 
(predominately type I fibres), extensor digitorum longus (predominately type II fibres) 
and plantaris (mix of type I and II fibres), should be characterized to determine whether 
specific muscle types are affected more than others. Western blot analysis for the 
contractile protein MHC is a technique that quantifies MHC isoform expression, in turn, 
defining fibre type composition of skeletal muscle tissue (Galpin et al., 2012; Quinn et al., 
1995). Additionally, multicolour immunofluorescence analysis is a more precise 
technique for determining muscle fibre type composition as it allows for quantification of 
multiple MHC isoforms simultaneously (Bloemberg & Quadrilatero, 2012).  
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It is documented there are over 3,000 genes that are differentially expressed 
between male and female skeletal muscles, suggesting gender differences may be seen 
due to hypermethylation (Welle et al., 2008). Additionally, male and female mice express 
variations in fibre type composition within the same muscle. For example, males express 
58% type IIa muscle fibres, whereas, females express only 36% in mice SOL (Haizlip et 
al., 2015). These differences are also seen in the plantaris (IIa - 16%, males; 37%, 
females) and tibialis anterior (IIa - 39%, males; 25%, females) (Haizlip et al., 2015). 
Moreover, MHC isoform composition is highly correlated with contractile function, 
especially the rate of force development and rate of relaxation, as well as, the enzymatic 
makeup of skeletal muscle tissue (Haizlip et al., 2015). Therefore, future research should 
examine sex-specific differences of offspring skeletal muscle fibre type composition, 
contractile function, and metabolism to a maternal supplemented folic acid diet. 
Lastly, future research should aim to study the effects of a maternal folic acid 
supplemented diet on offspring skeletal muscle tissue in humans. The results from this 
study indicate high levels of maternal folic acid does not appear to have significant 
implications on offspring skeletal muscle function and metabolism at young adulthood in 
rodents, however, the results from this study cannot be directly applied to a human 
population. Although human and rodent skeletal muscle tissue have similar 
characteristics, future work is necessary in human populations to confirm these findings.   
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APPENDIX A: Supplementary Results 
 
Table A.1 Dietary Composition of Control and Folic Acid Supplement Diets. 
 
Ingredient CON FA 
Formula (g/kg)   
Folic Acid 0.002 0.008 
Casein, “Vitamin-Free” Test 200 200 
L-Cystine 3 3 
Corn Starch 397.5 397.5 
Maltodextrin 132 132 
Sucrose 100 100 
Soybean Oil 70 70 
Cellulose 50 50 
Mineral Mix 53 53 
Vitamin Mix 20 20 
Choline Bitartrate 3.5 3.5 
TBHQ, antioxidant 0.014 0.014 
Energy Contribution (% kcal)   
Protein 19.4 19.4 
Carbohydrate  63.8 63.8 
Fat  16.7 16.7 
Relative Quantity (% by weight)   
Protein 18.3 18.3 
Carbohydrate 60.1 60.1 
Fat 7.0 7.0 
Total Energy (kcal/g) 3.8 3.8 
CON: control modified AIN93G diet (TD.06706; Harlan Teklad); FA: folic acid 
supplemented AIN93G diet (TD.140396; Harlan Teklad); TBHQ: tertiary 
butylhydroquinone 
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Table A.2. Effect of a supplemental folic acid diet on male offspring CD-1 mice soleus 
(SOL) and extensor digitorum longus (EDL) muscle isometric contractile function 
normalized to force. 
 
 CON FA 
SOL   
TPT/force (ms/mN) 1.28 ± 0.12 1.35 ± 0.13 
½ RT/force (ms/mN) 1.83 ± 0.32 1.68 ± 0.21 
+dP/dt/force  0.055 ± 0.001 0.054 ± 0.002 
-dP/dt/force 0.016 ± 0.002 0.014 ± 0.002 
EDL   
TPT/force (ms/mN) 0.22 ± 0.02 0.20 ± 0.01 
½ RT/force (ms/mN) 0.25 ± 0.03 0.22 ± 0.02 
+dP/dt/force 0.087 ± 0.001 0.087 ± 0.001 
-dP/dt/force 0.040 ± 0.002 0.041 ± 0.002 
Values are mean ± SEM. CON, n=9; FA, n=8; * denotes significance CON; CON, 2mg 
folic acid/kg diet; FA, 8mg folic acid/kg diet; SOL, soleus; EDL, extensor digitorum 
longus; TPT, time-to-peak tension; ½ RT, half relaxation time; +dP/dt, rate of 
contraction; -dP/dt, rate of relaxation.  
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Table A.3. Effect of a supplemental folic acid diet on male offspring CD-1 female soleus 
(SOL) and extensor digitorum longus (EDL) muscle isometric contractile function 
normalized to force. 
 
 CON FA 
SOL   
TPT/force (ms/mN) 1.34 ± 0.10 1.71 ± 0.21 
½ RT/force (ms/mN) 1.51 ± 0.10 1.92 ± 0.25 
+dP/dt/force  0.053 ± 0.001 0.048 ± 0.001* 
-dP/dt/force 0.014 ± 0.001 0.015 ± 0.001 
EDL   
TPT/force (ms/mN) 0.25 ± 0.01 0.28 ± 0.03 
½ RT/force (ms/mN) 0.33 ± 0.03 0.28 ± 0.03 
+dP/dt/force 0.086 ± 0.001 0.085 ± 0.002 
-dP/dt/force 0.031 ± 0.001 0.043 ± 0.003* 
Values are mean ± SEM. CON, n=9; FA, n=8; * denotes significance CON; CON, 2mg 
folic acid/kg diet; FA, 8mg folic acid/kg diet; SOL, soleus; EDL, extensor digitorum 
longus; TPT, time-to-peak tension; ½ RT, half relaxation time; +dP/dt, rate of 
contraction; -dP/dt, rate of relaxation.  
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APPENDIX B: Laboratory Procedures 
 
Part I: Sample Preparation 
Homogenization Buffer: 
- 50 mM Tris-HCl 
- pH 7.8 
- store at -4°C 
 
Homogenization Protocol: 
1. Weigh muscle tissue sample and add it to pre-chilled 2 mL glass homogenizer. 
2. Add homogenization buffer to achieve a 20:1 (w/v) dilution. 
3. Manually homogenize on ice (~5 min). 
4. Transfer sample to eppendorf. 
  
	  	  
	   	   	  110	  
Part II: Hexokinase Assay (EC: 2.7.1.1 // NADPH ε: 6.22)  
D-Glucose + ATP Hexokinase> D-Glucose + ADP 
D-Glucose 6 – Phosphate + β-NADP G-G-PHD> 6-PG + β-NADPH 
 Volume Substance Stock Final 
 765 µL Triethanolamine-HCl 
(pH 7.6) + EDTA + 
MgCl2 
50 mM buffer + 
5.32 mM EDTA + 
7.98 mM MgCl2 
5 mM EDTA + 
7.5 mM MgCl2 
 30 µL NADP (in fresh 
buffer) 
14 mM 0.42 mM 
 125 µL ATP (in fresh buffer) 20 mM 2.5 mM 
 10 µL Glucose-6-phosphate 
dehydrogenase (in 
distilled water) 
1 mg/mL 10 µg (~1.67 
U/mL) 
 50 µL Sample   
Initiate 
Reaction 
20 µL D(+)Glucose (in fresh 
buffer) 
111 mM 2.22 mM 
FINAL 1 mL    
 
 
Buffer: 
- 50 mM Triethanolamine-HCl 
- 5.32 mM EDTA 
- 9.80 mM MgCl2 
- pH 7.6 
- store at -4°C 
 
Protocol: 
1. Prepare buffer solution. 
2. Prepare and vortex reagent solutions: 
a. 0.5 mL of 14 mM NADP in buffer 
b. 2 mL of 20 mM ATP in buffer 
c. 2 mL of 111 mM D(+)Glucose in buffer 
d. 1 mg/mL of Glucose-6-phosphate dehydrogenase in distilled water 
* Note: Glucose-6-phosphate dehydrogenase dissolved in deionized water 
can be aliquoted and stored at -20°C for 2 months 
3. Pipette 1 mL of buffer into a 1 mL cuvette. 
4. Wipe down cuvette with Kim wipe and place into the spectrophotometer to 
reference absorbance at 340 nm. 
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5. Set up reaction kinetics program: 
a. Temperature: 25°C 
b. Wavelength: 340 nm 
c. Time: 15 min 
6. Pipette reagents into 1 mL cuvette in the following order: 
a. 765 µL buffer 
b. 30 µL NADP 
c. 125 µL ATP 
d. 10 µL Glucose-6-phosphate dehydrogenase  
e. 50 µL sample 
7. Invert, wipe down cuvette with Kim wipe and place into spectrophotometer. 
8. Run the assay for ~2 minutes to get a background reading. 
9. After 2 minutes, add 20 µL of D(+)Glucose to initiate the reaction, invert and wipe 
down with Kim wipe before placing back into spectrophotometer 
 * Ensure this is done quickly as this starts the reaction 
10. Record the slope of the background reading (between 0-2 minutes). 
11. Record the linear portion of the slope after the initiation of the reaction. 
 
 
References: 
 
Bass, A., Brdiczka, D., Eyer, P., Hofer, S., & Pette, D. (1969). Metabolic differentiation 
of distinct muscle types at the level of enzymatic organization. European Journal 
of Biochemistry, 10(2), 198-206. 
 
Thompson, A., & Cooney, G. (2000). Acyl-CoA inhibition of hexokinase in rat and 
human skeletal muscle is a potential mechanism of lipid-induced insulin 
resistance. Diabetes, 49(11), 1761-1765. 
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Part III: Phosphofructokinase Assay (EC: 2.7.1.11 // NADH ε: 6.22)  
Coupled Enzyme Assay System 
Fructose-6-phosphate + ATP Phosphofructokinase + Mg2+> F-1,6-diphosphate + ADP 
F-1,6-diphosphate Aldolase (excess)> Glyceraldehyde-3-phosphate + Dihydroxyacetone  
                                                                                          phosphate 
 
Glyceraldehyde-3-phosphate Triosephosphate isomerase (excess)> 
Dihydroxyacetonephosphate 
 
Dihydroxyacetonephosphate + NADH + H+ α-glycerophosphate dehydrogenase (excess)> 
Glycerol-1-phosphate + NAD+ 
 
 
 Volume Substance Stock Final 
 769 µL Tris-Base (pH 8.0) + 
MgCl2 + K2HPO4 
50 mM buffer + 2.08 
mM MgCl2 + 10.38 
mM K2HPO4 
2 mM MgCl2 
+ 10 mM 
K2HPO4 
 25 µL NADH (in fresh 
buffer) 
15 mM 0.375 mM 
 100 µL 5’AMP (in fresh 
buffer) 
10 mM 1 mM 
 20 µL α-Glycerophosphate 
Dehydrogenase 
100 U/mL 2 U/mL 
 2 µL Triosephosphate 
isomerase 
31 201.8 U/mL 62 U/mL 
 4.2 µL Aldolase 384 U/mL 1.61 U/mL 
 10 µL Sample   
 20 µL ATP (in fresh buffer) 50 mM 1 mM 
Initiate 
Reaction 
50 µL Fructose-6-
phosphate (in fresh 
buffer) 
50 mM 2.5 mM 
FINAL 1.0002 mL    
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Buffer: 
- 50 mM Tris-Base  
- 2.62 mM MgCl2 
- 13.09 mM K2HPO4 
- pH 8.0 
- store at -4°C 
 
Protocol: 
1. Prepare buffer solution. 
2. Prepare and vortex reagent solutions: 
a. 0.5 mL of 15 mM NADH in buffer 
b. 2 mL of 10 mM AMP in buffer 
c. 0.5 mL of 50 mM ATP in buffer 
d. 0.5 mL of 50 mM Fructose-6-phosphate in buffer 
3. Pipette 1 mL of buffer into a 1 mL cuvette. 
4. Wipe down cuvette with Kim wipe and place into the spectrophotometer to 
reference absorbance at 340 nm. 
5. Set up reaction kinetics program: 
a. Temperature: 25°C 
b. Wavelength: 340 nm 
c. Time: 15 min 
6. Pipette reagents into 1 mL cuvette in the following order: 
a. 769 µL buffer 
b. 25 µL NADP 
c. 120 µL AMP 
d. 20 µL α-Glycerophosphate dehydrogenase 
e. 2 µL Triosephosphate isomerase 
f. 4.2 µL Aldolase 
g. 10 µL sample 
h. 20 µL ATP 
* Add ATP immediately following the addition of the sample to stabilize 
PFK 
* α-Glycerophosphate dehydrogenase, Triosephosphate isomerase, and 
aldolase were added in excess to show maximal enzymatic activity of 
PFK 
* Mg2+ concentration was kept higher than ATP concentration to form Mg-
ATP complex and decrease the presence of ATP molecules that may 
inhibit PFK activity 
7. Invert, wipe down cuvette with Kim wipe and place into spectrophotometer. 
8. Run the assay for ~2 minutes to get a background reading. 
9. After 2 minutes, add 50 µL of fructose-6-phosphate to initiate the reaction, invert 
and wipe down with Kim wipe before placing back into spectrophotometer 
 * Ensure this is done quickly as this starts the reaction 
10. Record the slope of the background reading (between 0-2 minutes). 
11. Record the entire slope after the initiation of the reaction. 
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Reference: 
 
Passonneau, J., & Lowry, O. (1993). A collection of enzyme assays. In Enzymatic 
Analysis. Humana Press, New York), pp. 292-293. 
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Part IV: Carnitine Palmitoyltransferase Assay (EC: 2.3.1.21 // TNB ε: 13.6)  
Palmitoyl-CoA + Carnitine CPT I> Palmitoyl-carnitine + CoA-SH 
CoA-SH + dithionitrobenzoic acid (DTNB)         > CoA-S-S-TNB + thionitrobenzoic acid 
(TNB) 
 
 Volume Substance Stock Final 
 165 µL Tris-HCl (pH 8.0) + 
EDTA 
116 mM buffer + 
1.28 mM EDTA 
1.1 mM EDTA  
 25 µL DTNB (in fresh 
buffer) 
2.4 mM 0.24 mM 
 20 µL Palmitoyl-CoA (in 
water) 
1 mM 0.08 mM 
 25 µL L-Carnitine (in fresh 
buffer) 
11 mM 1.1 mM 
Initiate 
Reaction 
15 µL Sample   
FINAL 250 µL    
 
Buffer: 
- 116 mM Tris-HCl 
- 1.28 mM EDTA 
- pH 8.0 
- store at -4°C 
 
Protocol: 
1. Prepare buffer solution. 
2. Prepare and vortex reagent solutions: 
a. 4 mL of 2.4 mM DTNB in buffer 
b. 2 mL of 11 mM L-Carnitine in buffer 
c. 30 µL of 1 mM Palmitoyl-CoA in distilled water 
* Note: Palmitoyl-CoA dissolved in deionized water can be aliquoted and 
stored at -20°C for 2 months 
3. Pipette 250 mL of buffer into a 250 mL cuvette. 
4. Wipe down cuvette with Kim wipe and place into the spectrophotometer to 
reference absorbance 412. 
5. Set up reaction kinetics program: 
a. Temperature: 25°C 
b. Wavelength: 412 nm 
c. Time: 15 min 
6. Pipette 40 µL of sample into an Eppendorf tube. 
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7. Freeze-thaw the sample in liquid nitrogen 3 times to ensure rupture of the 
mitochondria. 
* Final thaw is done immediately prior to adding to reaction 
8. Pipette reagents into 250 mL cuvette (Cuvette A) in the following order: 
a. 165 µL buffer 
b. 25 µL DTNB 
c. 20 µL Palmitoyl-CoA 
d. 25 µL L-Carnitine  
9. Pipette reagents into 250 mL cuvette (Cuvette B) in the following order: 
a. 190 µL buffer (L-carnitine is replaced by buffer) 
b. 25 µL DTNB 
c. 20 µL Palmitoyl-CoA 
10. Invert, wipe down cuvettes with Kim wipe and place into spectrophotometer. 
11. Run the assay for ~2 minutes to get a background reading before initiating the 
reaction. 
12. After 2 minutes, add 15 µL of sample into each cuvette (A & B) to initiate the 
reactions, invert and wipe down with Kim wipe before placing back into 
spectrophotometer 
 * Ensure this is done quickly as this starts the reaction 
13. Record the slope of the background reading (between 0-2 minutes) for cuvette A 
and B. 
14. Record the first 2 minutes of the slope after the initiation of the reaction for 
cuvette A and B. 
 
 
Reference: 
 
Bieber, L., Abraham, T., & Helmrath, T. (1972). A rapid spectrophotometric assay for 
carnitine palmitoyltransferase. Analytical Biochemistry, 50(2), 509-518. 
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Part V:  3(β)-Hydroxyacyl-CoA Dehydrogenase (EC: 1.1.1.35 // NADH ε: 6.22)  
Acetyoacetyl-CoA + NADH β-hydroxyacyl dehydrogenase> NAD
+ + β-hydroxyacyl-CoA 
 Volume Substance Stock Final 
 215 µL Triethanolamine-HCl 
(pH 7.0) + EDTA  
120 mM buffer + 
5.55 mM EDTA 
5 mM EDTA  
 10 µL NADH (in fresh 
buffer) 
5.625 mM 0.225 mM 
 20 µL Sample   
Initiate 
Reaction 
5 µL Acetoacetyl-CoA (in 
water) 
5 mM 0.1 mM 
FINAL 250 µL    
 
Buffer: 
- 120 mM Triethanolamine-HCl 
- 5.55 mM EDTA 
- pH 7.0 
- store at -4°C 
 
Protocol: 
1. Prepare buffer solution. 
2. Prepare and vortex reagent solutions: 
a. 2 mL of 5.625 mM NADH in buffer 
b. 20 µL of 5 mM Acetoacetyl-CoA in distilled water 
* Note: Acetoacetyl-CoA dissolved in deionized water can be aliquoted 
and stored at -20°C for 3 months 
3. Pipette 250 mL of buffer into a 250 mL cuvette. 
4. Wipe down cuvette with Kim wipe and place into the spectrophotometer to 
reference absorbance at 340 nm. 
5. Set up reaction kinetics program: 
a. Temperature: 25°C 
b. Wavelength: 340 nm 
c. Time: 15 min 
6. Pipette reagents into 250 mL cuvette in the following order: 
a. 215 µL buffer 
b. 10 µL NADH 
c. 20 uL sample 
7. Invert, wipe down cuvette with Kim wipe and place into spectrophotometer. 
8. Run the assay for ~2 minutes to get a background reading before initiating the 
reaction. 
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9. After 2 minutes, add 5 µL of acetyoacetyl-CoA to initiate the reaction, invert and 
wipe down with Kim wipe before placing back into spectrophotometer. 
 * Ensure this is done quickly as this starts the reaction 
10. Record the slope of the background reading (between 0-2 minutes). 
11. Record the first 45 seconds of the slope after the initiation of the reaction. 
 
 
Reference: 
 
Bass, A., Brdiczka, D., Eyer, P., Hofer, S., & Pette, D. (1969). Metabolic differentiation 
of distinct muscle types at the level of enzymatic organization. European Journal 
of Biochemistry, 10(2), 198-206. 
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Part VI: Citrate Synthase Assay (EC: 2.3.3.1 // DTNB ε: 13.6)  
Oxaloacetate + Acetyl-CoA Citrate Synthase> Citrate + CoA-SH 
CoA-SH + dithionitrobenzoic acid (DTNB)         > CoA-S-S-TNB + thionitrobenzoic acid  
(TNB) 
 
 Volume Substance Stock Final 
 200 µL dH2O   
 10 µL DTNB (in buffer) 2.5 mM 0.1 mM 
 12.5 µL Acetyl-CoA (in water) 10 mM 0.5 mM 
 12.5 µL Triton X-100 (in 
water) 
10% (w/v)  0.5% 
 2.5 µL Sample   
Initiate 
Reaction 
12.5 µL Oxaloacetate (in 
buffer) 
10 mM 0.5 mM 
FINAL 250 µL    
 
DTNB Buffer: 
- 1.0 M Tris-HCl 
- pH 8.1 
- store at -4°C 
 
Oxaloacetate Buffer: 
- 0.1 M Tris-HCl 
- pH 8.1 
- store at -4°C 
 
Protocol: 
1. Prepare buffer solution. 
2. Prepare and vortex reagent solutions: 
a. 4 mL of 2.5 mM DTNB in DTNB buffer 
b. 4 mL of 10 mM oxaloacetate in oxaloacetate buffer 
c. 20 µL of 10% (w/v) Triton X-100 in distilled water 
d. 20 µL of acetyl-CoA in distilled water  
* Note: Acetyl-Coa dissolved in deionized water can be aliquoted and 
stored at -20°C for 2 weeks or -80°C for 6 months 
3. Pipette 10 µL of sample into an Eppendorf tube. 
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4. Freeze-thaw the sample in liquid nitrogen 3 times to ensure rupture of the 
mitochondria. 
* Final thaw is done immediately prior to adding to reaction 
5. Pipette 250 mL of distilled water into a 250 mL cuvette. 
6. Wipe down cuvette with Kim wipe and place into the spectrophotometer to 
reference absorbance at 412 nm. 
7. Set up reaction kinetics program: 
a. Temperature: 25°C 
b. Wavelength: 412 nm 
c. Time: 15 min 
8. Pipette reagents into 250 mL cuvette in the following order: 
a. 200 µL distilled water 
b. 10 µL DTNB 
c. 12.5 µL Acetyl-CoA 
d. 12.5 µL Triton X-100  
e. 2.5 µL sample 
9. Invert, wipe down cuvette with Kim wipe and place into spectrophotometer. 
10. Run the assay for ~2 minutes to get a background reading before initiating the 
reaction. 
11. After 2 minutes, add 12.5 µL of oxaloacetate to initiate the reaction, invert and 
wipe down with Kim wipe before placing back into spectrophotometer 
 * Ensure this is done quickly as this starts the reaction 
12. Record the slope of the background reading (between 0-2 minutes). 
13. Record the linear portion of the slope after the initiation of the reaction. 
 
 
Reference: 
 
Srere, P. (1969). Citrate synthase. In Methods in Enzymology, ed Lowenstein JM. 
(Academic, New York), pp. 305.   
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Part VII: Cytochrome C Oxidase Assay (EC: 1.9.3.1 // Cytochrome C ε: 29.5)  
4 Ferrocytochrome C (reduced) + O2 + 4H+ 
       
> 4 Ferricytochrome C (oxidized) + 2H2O 
 
 Volume Substance Stock Final 
 610 µL Phosphate Buffer (pH 
7.4)  
30 mM  
 300 µL Tween 20 10% 3% 
 10 µL Sample   
Initiate 
Reaction 
80 µL Cytochrome C (in fresh 
buffer) 
0.5 mM 0.04 mM 
FINAL 1 mL    
 
 
Buffer: 
- 26.4 mM potassium phosphate dibasic  
- 9.9 mM potassium phosphate monobasic  
- pH 7.4 
- store at -4°C 
 
Protocol: 
1. Prepare buffer solution. 
2. Prepare and vortex 1 mL of 0.5 mM cytochrome C in buffer  
3. Pipette 250 mL of distilled water into a 250 mL cuvette. 
4. Wipe down cuvette with Kim wipe and place into the spectrophotometer to 
reference absorbance at 550 nm. 
5. Add 240 µL of distilled water and 10 µL of cytochrome C to a 250 mL cuvette. 
6. Test absorbance at 550 nm and 565 nm. 
7. Calculate the absorbance ratio of 550 nm/565nm. 
* Ratio should be between 8-11 
* If cytochrome C solution is too oxidized (ratio above 11), add a pinch of sodium 
hydrosulfite to reduce it 
* If cytochrome C solution is too reduced (ratio below 8), slowly bubble oxygen 
into the solution to oxidize it 
8. Set up reaction kinetics program once the ratio is between 8-11: 
a. Temperature: 25°C 
b. Wavelength: 550 nm 
c. Time: 15 min 
9. Pipette 15 µL of sample into an Eppendorf tube. 
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10. Freeze-thaw the sample in liquid nitrogen 3 times to ensure rupture of the 
mitochondria. 
* Final thaw is done immediately prior to adding to reaction 
11. Pipette reagents into 1 mL cuvette in the following order: 
a. 610 µL buffer 
b. 300 µL Tween 20 
c. 10 µL sample 
12. Invert, wipe down cuvette with Kim wipe and place into spectrophotometer. 
13. Run the assay for ~2 minutes to get a background reading before initiating the 
reaction. 
14. After 2 minutes, add 80 µL of cytochrome C to initiate the reaction, invert and 
wipe down with Kim wipe before placing back into spectrophotometer 
 * Ensure this is done quickly as this starts the reaction 
15. Record the slope of the background reading (between 0-2 minutes). 
16. Record the first 45 seconds of the slope after the initiation of the reaction. 
 
 
Reference: 
 
Cooperstein, S., & Lawarow, A. (1950). A microspectrophotometric method for the 
determination of cytochrome oxidase. Journal of Biological Chemistry, 189(2), 
665-670. 
 
